3
Views
0
CrossRef citations to date
0
Altmetric
Literature Alerts

Literature Alerts

Pages 419-440 | Published online: 27 Sep 2008

LITERATURE ALERTS

  • All-Union program 'Liposomes and their use in biology and medicine' (the research and research-practice parts of the program). Vestn. Akad. Med. Nauk. SSSR, 1990, (6), 4–7.
  • The effect of lipid composition upon the encapsulation and in vitro leakage of metaproterenol sulfate from 0.2 pm diameter extruded multilamellar liposomes. ABRA, R. M., MIHALKO, P. J., and SCHREIER, H., J, Controlled Release, 1990, 14, (1), 71–78.
  • Production and characterization of improved liposomes containing radiographic contrast media. ADZAMLI, I. K., SELTZER, S. E., SLIFKIN, M., BLAU, M., and ADAMS, D. F., Invest, Radiol., 1990, 25, (11), 1217–1223.
  • 5'-S-(2-Aminoethyl)-N6-(4-nitrobenzy1-5'-thioadenosine (SAENTA), a novel ligand with high affinity for polypeptides associated with nucleoside transport. Partial purification of the nitrobenzylthioinosine-binding protein of pig erythrocytes by affinity chromatography. AGBANYO, F. R., VIJAYALAKSHMI, D., CRAIK, J. D., GATI, W. P., McAnAm, D. P., ASAKURA, J., ROBINS, M. J., PATERSON, A. R. P., and CASS, C. E., Biochem. J., 1990, 270 (3), 605–614.
  • Detection of the emission of neutral atoms during laser compression of microspheres. A1IMAD, Z., EROKHIN, A. A., ZAKHARENKOV, Yu. A., KARNAUKHOV, A. A., KHOLL, T. A., and SHIKANOV, A. S. Pis'ma Zh. Eksp. Teor. Fiz., 1990, 51, (11), 553–556.
  • Effect of cytochrome P-450 on organization of liposomes from phosphatidylcholine and its mixture with phosphatidylethanolamine and phosphatidylglycerol. AKHREM, A. A., ROMANOV, S. L., STRIZHAKOVA, E. P., OKUN, I. M., KONEV, S. V., and KISELEV, P. A. Vesti Akad. Nauk BSSR, Ser. Khim. Nauk, 1990, (4), 74–78.
  • Effect of surfactants on the stability of modified egg-yolk phosphatidylcholine liposomes. ALAMELU, S., and RAO, K. P., J. Microencapsulation, 1990, 7, (4), 541–552.
  • Structural modifications in the distearoylphosphatidylcholine liposomes induced by variable cholesterol concentration. ALBERTINI, G., AMBROSINI, A., DUBIN', B., PoNzi-Bosst, M. G., and Boss', G., Nuovo Cimento Soc. Ital. Fis., D, 1990, 12D, (9), 1309–1316.
  • Thermodynamic and structural effects of propranolol on DPPC liposomes. ALBFRTINI, G., DONATI, C., PHADKE, R. S., PoNzi-Bosst, M. G., and RUSTICHELLI, F., Chem. Phys. Lipids, 1990, 55, (3), 331–337.
  • Encapsulation of water-soluble drugs by a modified solvent evaporation method. I. Effect of process and formulation variables on drug entrapment. ALEX, R., and BODMEIER, R., J. Microencapsulation, 1990, 7, (3), 347–355.
  • High encapsulation efficiencies in sized liposomes produced by extrusion of dehydration-rehydration vesicles. ALINO, S. F., GARCIA-SANZ, M., IRRUARRIZAGA, A., ALFARO, J., and HERNANDEZ, J., J. Microencapsulation, 1990, 7, (4), 497–504.
  • Joint effects of monomer and stabilizer concentrations on physico-chemical characteristics of polybutyI-2-cyanoacrylate nanoparticles. ALONSO, M. J., SANCHEZ, A., TORRES, D., SEuo, B., and VILA-JATO, J. L., J. Microencapsulation, 1990, 7, (4), 517–526.
  • Estimation by FACS of the delivery of liposome encapsulated macromolecules into myeloid cells. ALPAR, H. 0., BASON, A. M., HICKMAN, J. A., RICHARDS, F. M., and FIELD, W. N., Int. J. Pharm., 1990, 62, (2-3), 133–141.
  • Antibodies to liposomes, phospholipids, and cholesterol: implications for autoimmunity, atherosclerosis, and aging. ALviNG, C. R., Prog. Clin. Biol. Res., 1990, 343 (Horiz. Membr. Biotechnol.), 41–51.
  • Liposomes as carriers of vaccines: development of a liposomal malaria vaccine. ALV1NG, C. R., RICHARDS, R. L., HAYRE, M. D., HOCKMEYER, W. T., and WIRTZ, R. A., NATO ASI Ser., Ser. A, 1989, 179 (Immunol. Adjuvants Vaccines), 123–131.
  • Liposomes containing lipid A: a potent nontoxic adjuvant for a human malaria sporozoite vaccine. ALVING, C. R., and RICHARDS, R. L., Immunol. Lett., 1990, 25, (1-3), 275–279.
  • The effect of temperature on the solubilization stages of lecithin liposomes by sodium deoxycholate. AMBARTSUMYAN, T. G., MARIKYAN, G. G., and PETROSYAN, L. S., Biol. Zh. Arm., 1990, 43, (1), 64–66.
  • In vitro release kinetic pattern of indomethacin from poly(n,L-lactide) nanocapsules. AMMOURY, N., FESSI, H., DEVISSAGUET, J. P., PUISIEUX, F., and BENITA, S., J. Pharm. Sci., 1990, 79, (9), 763–767.
  • Effect of cerebral blood flow of orally administered indomethacin-loaded poly(isobutyl cyanoacrylate) and poly(m-lactide) nanocapsules. AMMOURY, N., FESSI, H., DEV1SSAGUET, J. P., ALL1X, M., PLOTKINE, M., and BouLu, R. G., J. Pharm. Pharmacol., 1990, 42,(8), 558–561.
  • Immunoadjuvant studies of IL-2 liposomes against cancer: murine pharmacokinetic and anti-tumor efficacy studies using intracavitary routes of administration. ANDERSON, P. M., KATSANIS, E., RICH, M., LEONARD, A. S., LOEFFLER, C. M., and OCHOA, A. C., J. Cell. Biochern. Suppl., 1990, (14, Part B), 93.
  • Pharmacokinetics or intra-arterial mitomycin C with or without degradable starch micro-spheres (DSM) in the treatment of resectable liver cancer. ANDERSSON, M., ARONSEN, K. F., BALCH, C. DOMELLOF, L., EKSBORG, S., HAFSTROM, L. 0., HOWELL, S. B., KARESEN, R., MIDANDER, J., and TEDER, H., Oncologia Madr., 1990, 13, (6), 277–281.
  • Flow cytometric analysis of immunophagocytosis using sensitized fluorescent microspheres bearing C3b. ANDOH, A., FUJIYAMA, Y., HIROTANI, S., HODOHARA, K., BAMBA, T., and HOSODA, S., Nippon Ketsueki Gakkai Zasshi, 1990, 53, (3), 567–574.
  • Immunogenic and protective activity of influenza virus hemagglutinin conjugated with synthetic microspheres. ANDREEV, S. M., SINYAKOV, M. S., NORIMOV, A. Su., and SHIKUNOVA, 0. A., Immunologiya, 1990, (1), 36–38.
  • Influence of dextran sulfate on the fusion of Sendai virus with liposomes. ARNOLD, K., and Oulu, S., Biomed. Biochim. Acta, 1990, 49, (7), 633–635.
  • Interaction of dextran sulfate with phospholipid surfaces and liposome aggregation and fusion. ARNOLD, K., OHKI, S., and KRUMBIEGEL, M., Chem. Phys. Lipids, 1990, 55, (3), 301–308.
  • Rotational mobility of Sendai virus glycoproteins in membranes of fused human erythrocytes and in the envelopes of cell-bound virions. AROETI, B., JoviN, T. M., and HENIS, Y. I., Biochemistry, 1990, 29, (39), 9119–9125.
  • Immunomodulation by liposome-entrapped allergen. ARORA, N., and GANGAL, S. V., Mol. Cell Biochem., 1990, 97, (2), 173–179.
  • Albumin microspheres and microcapsules: methodology of manufacturing techniques. ARSHADY, R., J. Controlled Release, 1990, 14, (2), 111–132.
  • Biodegradable microcapsular drug delivery systems: manufacturing methodology, release control and targeting prospects. ARSHADY, R., J. Bioact. Compat. Polym., 1990,5, (3), 315–342.
  • Preparation of sterically stabilized nanoparticles by desolvation from graft copolymers. ARTURSSON, P., BROWN, L., Dix, J., GODDARD, P., and PETRAK, K., J. Polym. Sci., Part A: Polym. Chem., 1990, 28, (10), 2651–2663.
  • In vitro transfer of apolipoproteins from plasma lipoproteins to artificial lipid particles. ASAMI, H., and IRIYAMA, K., Nutrition, 1990, 6, (2), 143–145.
  • Bioavailability of controlled release indomethacin microspheres and pellets. AVGERINOS, A., and MALAMATARIS, S., Int. J. Pharm., 1990, 63, (1), 77–80.
  • A study of stabilization effect of alpha-tocopherol incorporated into liposomal phospholipid membrane. BAE SONG JA, and KIM NAM HONG, Arch. Pharmacol. Res., 1990, 13, (1), 64–68. Antigen presentation by liposomes bearing class II MHC and membrane IL-1. BAKOUCHE, 0., and LACHMAN, L. B., Yale J. Biol. Med., 1990, 63, (2), 95–107.
  • Synthetic macrophages: liposomes bearing antigen, class II MHC and membrane-IL-1. BAKOUCHE, 0., and LACHMAN, L. B., Lymphokine Res., 1990, 9, (3), 259–281.
  • Mechanism of transmembrane photosensitized electron transfer in liposomes containing pheophytin. BARANNIKOVA, VA. V., NADTOCHENKO, V. A., NIKANDROV, V. V., RUBTSOV, I. V., and KRASNOVSKII, A. A., Dokl. Akad. Nauk. SSSR, (Biophys.), 1990, 312, (3), 743–747.
  • Possibility of incorporation of macromolecules including exogenous DNA into sex cells: the liposome method and calcium-phosphorus coprecipitation method. BARANOV, V. Z., BRZOBOGATYI, B., TSYMBALENKO, N. V., TA1DLICHEK, L., GORBUNOVA, V. N., KAZAKOVA, T. B., KOVACH, L., and BODYA, K., Tsitol. Genet., 1990, 24, (2), 52–55.
  • Polyacrylate (Eudragit Retard) microspheres for oral controlled release of nifedipine. I. Formulation design and process optimization. BARKAI, A., PATHAK, Y. V., and BENITA, S., Drug Dev. Ind. Pharm., 1990, 16, (13), 2057–2075.
  • Characteristics of Albunex air-filled albumin microspheres for echocardiography contrast enhancement. BARNHART, J., LEVENE, H., VILLAPANDO, E., MANIQUIS, J., FERNANDEZ, J., RICE, S., JABLONSKI, E., GjoEN, T., and TOLLESHAUG, H., Invest. Radial., 1990, 25, (Suppl. 1), S162–S164.
  • Differential scanning calorimetry study of the interaction of antidepressant drugs noradrena-line and 5-hydroxytryptamine with a membrane model. BAUER, M., MEGRET, C., LAMURE, A., LACABANNE, C., and FAURAN-CLAVEL, M. J., J. Pharm. Sci., 1990, 79, (10), 897–901.
  • Separation of drug-loaded nanoparticles from free drug by gel filtration. BECK, P., SCHERER, D., and KREUTER, J., J. Microencapsulation, 1990, 7, (4), 491–496.
  • Use of liposome encapsulated sodium 2,3-dimercaptopropanesulfonate (DMPS) in the treat-ment of mice loaded with cadmium. BEHARI, J. R., GUPTA, S., SRIVASTAVA, S., and SRIVASTAVA, R. C., J. Environ. Sci. Health, Part A, 1990, A25, (6), 597–610.
  • The interactions of autoliposomes with tumor cells. BEKRENEVA, V. Yu., Znuixov, A. G., SHALDZHYAN, A. A., REZNIKOVSKII, Yu. S., and ROZENBERG, 0. A., Biol. Membr., 1990,7, (3), 289–296.
  • Complement component C3 fixes selectively to the major outer membrane protein (MOMP) of Legion ella pneumophila and mediates phagocytosis of liposome-MOMP complexes by human monocytes. BELLINGER-KAWAHARA, C., and HORWITZ, M. A., J. Exp. Med., 1990, 172, (4), 1201–1210.
  • Interaction of the isolated chromosomes with the liposomes. BELYAEV, N. D., BUDKER, V. G., BALAKIREVA, L. A., and DUBROVSKAYA, N. A., Cell Biol. Int. Rep., 1990, 14, (Abstr. Suppl.), 80.
  • Microspheres of hyaluronic acid esters-fabrication methods and in vitro hydrocortisone release. BENEDETTI, L. M., TOPP, E. M., and STEI.LA, V. J., J. Controlled Release, 1990, 13, (1), 33–41.
  • Problems in development of liposomes containing antibiotics. BEREZOVSKAYA, L. N., GRYAZNOVA, N. S., BAIRAMASHVILI, D. I., and YAROTSKII, S. V., Antiobiot. Khimioter., 1990, 35, (10), 31–35.
  • NMR study of the interaction of beta-blockers with sonicated dimyristoylphosphatidylcholine liposomes in the presence of praseodymium cation. BETAGERI, G. V., THERIAUI.T, Y., and ROGERS, J. A., Membr. Biochem., 1990, 8, (4), 197–206.
  • Synthesis of nanocomposite particles by intravesicular coprecipitation. BHANDARKAR, S., and BOSE, A., J. Colloid Interface Sc., 1990, 139, (2), 541–550.
  • Differential scanning calorimetry and Fourier transform infrared analysis of lipid-protein interactions involving the nicotinic acetylcholine receptor. BHUSHAN, A., and MCNAMEE, M. G., Biochim. Biophys. Acta, 1990, 1027, (1), 93–101.
  • Effect of lipid composition on the transfer of sterols mediated by non-specific lipid transfer protein (sterol carrier protein2). BILLHEIMER, J. T., and GAYLOR, J. L., Biochim. Biophys. Acta, 1990, 1046, (2), 136–143.
  • Effect of glycerol on the interfacial properties of dipalmitoylphosphatidylcholine liposomes as measured with merocyanine 540. BIONDI, A. C., and DISAI.VO, E. A., Biochim. Biophys. Acta: 1990, 1028, (1), 43–48.
  • Fatty acid composition in human erythrocyte ghosts sarcolemma and sarcoplasmic reticulum in muscular diseases. BIRKLE, D. L., RIGGS, J. E., Lum, J. A., JOHNSON, E. A., and AZZARO, A. J., Ann. Neurol., 1990, 28, (2), 273.
  • Kinetic characterization of the reconstituted tricarboxylate carrier from rat liver mito-chondria. BISACCIA, F., DE PALMA, A., PREZIOSO, G., and PALMIERI, F., Biochim. Biophys. Acta, 1990, 1019, (3), 250–256.
  • Characterization of degradable starch microspheres as a nasal delivery system for drugs. BJOERK, E., and EDMAN, P., Int. J. Pharm., 1990, 62, (2-3), 187–192.
  • Effect of integral membrane proteins on the lateral mobility of plastoquinone in phosphatidyl-choline proteoliposomes. BLACKWELL, M. F., and WHITMARSH, J., Biophys. J., 1990, 58, (5), 1259–1272.
  • Purification of a stilbene sensitive chloride channel and reconstitution of chloride conductiv-ity into phospholipid vesicles. BLATR, H. C., and SCHLESINGER, P. FL, Biochem. Biophys. Res. Commun., 1990, 171, (3), 920–925.
  • Liposomes for sustained drug release in vivo. BLUME, G., and CEVC, G., Biochim. Biophys. Acta, 1990, 1029, (1), 91–97.
  • Sizing nanoparticles by means of elliptically polarized scattered light: a suggested method. BOHREN, C. F., Part. Part. Syst. Charact., 1990, 7, (3), 107–112.
  • Fatty acid-binding to erythrocyte ghost membranes and transmembrane movement. BOJESEN, 1. N., and BOJESEN, E., Mol. Cell. Biochem., 1990, 98, (1-2), 209–216.
  • Effect of the addition of ceramide to dioleoylphosphatidylcholine vesicles: an ESR and SEM study. BONOSI, F., GABRIELLI, G., MARGHERI, E., and MARTINI, G., Langmuir, 1990, 6, (12), 1769–1773.
  • Effects of the intracellular administration by using liposomes of inositol triphosphate and Inositol tetraphosphate in aortic smooth muscle. BRAILOIU, E., COTRUTZ, C., and BRANISTEANU, D. D., Cell. Biol. Inst. Rep., 1990, 14, (Abstr. Suppl.), 109.
  • Liposome preparation by a new high pressure homogenizer Gaulin Micron LAB 40. BRANDL, M., BACHMANN, D., DRECHSLER, M., and BAUER, K. H., Drug. Dev. Ind. Pharm., 1990, 16, (14), 2167–2191.
  • The retention of entrapped molecules within erythrocyte ghosts during cryopreservation. BREARLEY, C. A., HODGES, N. A., and OLLIFF, C. J., J. Pharm. Pharmacol., 1990, 42,(5), 297–301.
  • Tumour imaging with labelled liposomes (letter). BRIELE, B., HOTZE, A., OEHR, P., BIERSACK, H. J., ROSANOWSKI, F., GORGULLA, W., HERTBERHOLD, C., and HARLAPP, J. P., Lancet, 1990, 336, (8719), 875–876.
  • Mechanisms of delivery of liposome-encapsulated cytosine arabinoside to CV-1 cells in vitro. Fluorescence-microscopic and cytotoxicity studies. BROWN, P. M., and StLvms, J. R., Biochim. Biophys. Acta, 1990, 1023, (3), 341–351.
  • Mediated interaction between negatively charged polysaccharides and phosphatidylcholine vesicles in the presence of calcium ions. BUDKER, V. G., MARKUSHIN, Yu. YA., VAKHRUSHEVA, T. E., KISELEVA, E. V., MACTSEVA, T. V., and StDoRov, V. N., Biol. Membr., 1990,7, (4), 419–427.
  • Synaptic vesicles immunoisolated from rat cerebral cortex contain high levels of glutamate. BURGER, P. M., MEHL, E., CAMERON, P. L., MAYCOX, P. R., BAUMERT, M., LOTTSPEICH, F., DE CAM., P., and JAHN, R., Neuron, 1989, 3, (6), 715–720.
  • Practical analysis of complex coacervate systems. BURGESS, D. J., J. Colloid Interface Sci., 1990, 140, (1), 227–238.
  • Nafarelin controlled release injectable: theoretical clinical plasma profiles from multiple dosing and from mixtures of microspheres containing 2 per cent, 4 per cent and 7 per cent Nafarelin. BURNS, R. A. JR, VITALE, K., and SANDERS, L. M., J. Microencapsulation, 1990,7, (3), 397–413.
  • Optimization of the preparation method of poly(hydroxypropyl methacrylate) nanoparticles. CADIEUX, C., and LENAERTS, V., Acta Pharm. Technol., 1989, 35, (3), 160–162.
  • Intravascular transplantation of microencapsulated islets in diabetic dogs. CALAFIORE, R., BASTA, G., FALORNI, A., JR, Piccitio, M. L., BRoTzu, G., and BRUNETTI, P., Diabetologia, 1990,33, (Suppl.), A42.
  • Thiamin transport by human erythrocytes and ghosts. CASIROLA, D., PATRINI, C., FERRARI, G., and RIND, G., J. Membr. Biol., 1990, 118, (1), 11–18.
  • Modified hydrodynamic chromatography and its applications to liposomes. CFBAMANOS, F., VILA, A. 0., DIEGUEZ, P., FIGUERUELO, J., and MOLINA, F. J., J. High Resolut. Chromatogr., 1990, 13, (8), 583–584.
  • Interaction between cytochrome c and cardiolipin-containing liposome membrane. CHENG BOJI, DUNG YUZHI, QIAO YULAN, LIN KECHLIN, Yu QUN, YE JIANPING, and SHOU HANSEN, Shengwu Huaxue Zazhi, 1990, 6, (4), 362–366.
  • Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcome M 5076 metastasis-bearing mice. CHIANNILKULCHAI, N., AMMOURY, N., CAILLOU, B., DEVISSAGUET, J. P., and COUVREUR, P., Cancer Chemother. Pharmacol., 1990, 26, (2), 122–126.
  • In vitro evaluation of activation of peritoneal cells by alginate-polylysine-alfinate capsules. CHICHEPORTICHE, D., WATERFALL, M., REACH, G., and BAIRD, J. D., Diabetologia, 33, (Suppl.), A181.
  • Ultrastructural study of liposome uptake by M cells of rat Pe yer's patch: an oral vaccine system for delivery of purified antigen. CHILDERS, N. K., DENYS, F. R., McGRE, N. F., and MICHALEK, S. M., Reg. Immunolo., 1990, 3, (1), 8–16.
  • Efficiency of cytoplasmic delivery by pH-sensitive liposomes to cells in culture. CHu, C. J., DIJKSTRA, J., LAI, M. Z., HONG, K., and SZOKA, F. C., Pharm. Res., 1990, 7, (8), 824–834.
  • Ionically crosslinkable polyphosphazene: a novel polymer for microencapsulation. COHEN, S., BANO, M. C., VISSCHER, K. B., CHOW, M., At.t.cocR, H. R., and LANGER, R., J. Am. Chem. Soc., 1990, 112, (21), 7832–7833.
  • Proton and divalent cations induce synergistic but mechanistically different destabilizations of pH-sensitive liposomes composed of dioleoylphosphatidylethanolamine and oleic acid. COLLINS, D., CONNOR, J., TING BEALL, H. P., and HUANG, L., Chem. Phys. Lipids, 1990, 55, (3), 339–350.
  • Structural and functional comparisons of pH-sensitive liposomes composed of phosphatidyl-ethanolamine and three different diacylsuccinylglycerols. COLLINS, D., LITZINGER, D. C., and HUANG, L., Biochim. Biophys. Acta, 1990, 1025, (2), 234–242.
  • Leakage and delivery of liposome-encapsulated methotrexate-gamma-aspartate in a chemi-cally defined medium. COMISKEY, S. J., and HEATH, T. D., Biochim. Biophys. Acta, 1990,1024, (2), 307–317.
  • Serum-induced leakage of negatively-charged liposomes: effects on liposome-mediated delivery of methotrexate-gamma-aspartate. COMISKEY, S. J., University of Wisconsin, Madison, WI, USA, Dissertation, 1989, 116 pp.
  • Preparation and pharmacokinetic evaluation of a modified long-acting injectable nor-ethisterone microsphere formulation. CoNG, H., Adv. Contracept., 1990, 6, (4), 264.
  • Fusion of liposomes with rat brain microsomal membranes and modulation of phospha-tidylserine synthesis. In LEGER, C. L., and BEREZIAT, G., (eds), INSERM (National Institute of Health and Medical Research) Colloquium, Vol. 195. Biomembranes and Nutrition: Nutrients Affecting Lipid Composition and Properties of Cell Membranes, International Meeting, Paris, France, 12–14 June 1989, 575 pp. Les Editions INSERM: Paris, France, 1989, 502 pp.
  • Voltage activation of purified eel sodium channels reconstituted into artificial liposomes. CORREA, A. M., BEZANILLA, F., and AGNEW, W. S., Biochemistry, 1990, 29, (26), 6230–6240.
  • Nanoparticles as microcarriers for anticancer drugs. COUVREUR, P., ROBLOT TREUPEL, L., POUPON, M. F., BRASSEUR, F., and PUISIEUX, F., Adv. Drug Delivery Rev., 1990, 5, (3), 209–230.
  • Initial clinical trial of the macrophage activator muramyl tripeptide phosphatidyleth-anolamine encapsulated in liposomes in patients with advanced cancer. CREAVEN, P. J., COWENS, J. W., BRENNER, D. E., DADEY, B. M., HAN, T., HUBEN, R., KARAKOUSIS, C., FROST, H., LESHER, D., et al., J. Biol. Response Modi f., 1990, 9, (5), 492–498.
  • Light driven amino acid uptake in membrane vesicles of Streptococcus cremoris fused with liposomes containing bacterial reaction centres. CRIELAARD, W., DRIESSEN, A. J. M., MOLENAAR, D., HELLINGWERF, K. J., and KONINGS, W. N., NATO ASI Ser., Ser. A, 1989, 168, (Tech. New Dev. Photosynth. Res.), 291–295.
  • Microencapsulation of mammalian cells in a HEMA-MMA copolymer: effects on capsule morphology and permeability. CROOKS, C. A., DOUGLAS, J. A., BROUGHTON, R. L., and SEFTON, M. V., J. Biomed. Mater. Res., 1990, 24, (9), 1241–1262.
  • Release of peptides from sustained delivery systems (microcapsules and microparticles) in vivo. A histological and immunohistochemical study. CSERNUS, V. J., SZENDE, B., and SCHALLY, A. V., Int. J. Pept. Protein Res., 1990, 35, (6), 557–565.
  • Limited proteolysis of bovine muscle and heart lactate dehydrogenase is inhibited by phospholipid liposome interaction. DABROWSKA, A., and CZAPINSKA, E., Biochim. Biophys. Acta, 1990, 1027, (3), 301–303.
  • Nanocapsules as carriers for oral peptide delivery. DAMGE, C., MICHEL, C., APRAHAMIAN, M., COUVREUR, P., and DEVISSAGUET, J. P., J. Controlled Release, 1990, 13, (2-3), 233–239.
  • Activation of complement by alginate-polylysine microcapsules. DARQUY, S., PUEYO, M. E., CAPRON, F., and REACH, G., Diabetologia, 1990, 33, (Suppl.), A181.
  • Limited proteolysis of bovine muscle and heart lactate dehydrogenase is inhibited by phospholipid liposome interaction. DCABROWSKA, A., and CZAPINSKA, E., Biochim. Biophys. Acta, 1990, 1027, (3), 301–303.
  • Potentialities of magnetoliposomes in studying symmetric and asymmetric phospholipid transfer processes. DE CUYPER, M., and JoNtAu, M., Biochim. Biophys. Acta, 1990, 1027, (2), 172–178.
  • Effect of nonionic surfactants on the permeability of liposomes. DE LA MAZA, A., GARCIA, M. T., RIBOSA, I., COMELLES, F., SANCHEZ LEAL, J., and PARRA, J. L., Comun. Jorn. Corn. Esp. Deterg., 1990, 21, 405–423.
  • Thermal nonlinearities of an aqueous polystyrene microsphere suspension. DE NICOLA, S., MORM ILE, P., PIERATTINI, G., ABBATE, G., BERN INI V., and MADDALENA, P., PrOC. SPIE-Int Soc. Opt. Eng., 1230, (Int. Conf. Optoelectron. Sci. Eng. '90, 1990), 120–123.
  • Light-dependent pH gradients are generated in liposomes containing ferrocyanide. DEAMER, D. W., and HARANG, E., Biosystems, 1990, 24, (1), 1–4.
  • Regulation of the maltose transport system of Escherichia coli by the glucose-specific enzyme III of the phosphoenolpyruvate-sugar phosphotransferase system. Characterization of inducer exclusion-resistant mutants and reconstitution of inducer exclusion in pro-teoliposomes. DEAN, D. A., REIZER, J., NIKAIDO, H., and SAIER, M. H. JR, J. Biol. Chem., 1990, 265, (34), 21005–21010.
  • Regulation of gene expression in vivo by liposome-mediated delivery of a purified transcrip-tion factor. DEBS, R. J., FREEDMAN, L. P., EDMUNDS, S., GAENSLER, K. L., DUZGUNES, N., and YAMAMOTO, K. R., J. Biol. Chem., 1990, 265, (18), 10189–10192.
  • What news in 1990 in blood substitutions: improvements of modified hemoglobin solutions and hemoglobins issued from biomedical and genetic engineering. DELIGNE, P., Urgences Med., 1990, 9, (2), 76–85.
  • The characteristics and application of liposome, anew drug carrier. DENG YINGJIE, and Gu XUE-Zhongguo Yaoxue Zazhi, 1990, 25, (4), 195–199.
  • Acyl chain packing properties of deuterated lipid bilayer dispersions, vibrational Raman spectral parameters. DEVLIN, M. T., and LEVIN, I. W., J. Raman Spectrosc., 1990, 21, (7), 441–451.
  • /n vitro release of an epimeric steroid from microcapsules. DEVRIES, T. M., Ohio State University, Columbus, OH, USA, Dissertation, 1989, 235 pp.
  • Development of pancreatic enzyme microsphere technology and US findings with pancrease in the treatment of chronic pancreatitis. DEYOUNG, J. L., Ira. J. Pancreatol., 1989, 5, (Suppl.), 31–36.
  • Calcium movements mediated by proteolipid protein and nucleotides in liposomes prepared with the endogenous lipids from brain white matter. DIAZ, R. S., MONREAL, J., and LUCAS, M., J. Neurochem., 1990, 55, (4), 1304–1309.
  • Ectericide as a dispersion medium for the preparation of prospective clinical liposomal drug forms. DIKII, I. L., STRECNIKOV, L. S., CHUESHOV, V. I., LUCOVENKO, V. D., and BAZAVLUK, A. D., Vestn. Akad. Med. Nauk. SSSR, 1990, (6), 40–44.
  • A contribution to the evaluation of microcapsules by light microscopy. DITTRICH, M., MELICHAR, L., and SEMECKY, V., J. Microencapsulation, 1990, 7, (4), 527–540.
  • Multiple transplantations of microencapsulated hepatocytes for sustained correction of hyperbilirubinemia in Gunn rats. DIXIT, V., ARTHUR, M., and GITNICK, G., Hepatology, 1990, 12, (4, Part 2), 860.
  • Hepatocyte plasma membrane repair using phosphatidylcholine liposomes. DOBRYNINA, 0. V., SHATININA, S. Z., and ARCHAKOV, A. I., Byull Eksp. Biol. Med., 1990, 110, (7), 94–96.
  • Phase diagrams of pseudo-binary phospholipid systems III. Influence of the head group methylation on the miscibility behavior of N-methylated phosphatidylethanolamine mixtures in aqueous dispersions. DOERFLER, H. D., MIETHE, P., and MoEP§, A., Chem. Phys. Lipids, 1990, 54, (3-4), 171–179.
  • Using liposomes for studies of lymphocyte membrane cyclic AMP transport. DONTSOV, V. I., Byull. Eksp. Biol. Med., 1990, 109, (3), 246–248.
  • The permeability of EUDRAGIT RL and HEMA-MMA microcapsules to glucose and inulin. DOUGLAS, J. A., and SEFTON, M. V., Biotechnol. Bioeng., 1990, 36, (7), 653–664.
  • Improvement of amphotericin B activity during experimental cryptococcosis by incorpor-ation into specific immunoliposomes. DROMER, F., BARBET, J., BOLARD, J., CHARREIRE, J., and YEN, P., Antimicrob. Agents Chemother., 1990, 34, (II), 2055–2060.
  • Ibuprofen-loaded ethylcellulose microspheres release studies and analysis of the matrix structure through the Higuchi model. DUBERNET, C., BENOIT, J. P., PEPPAS, N. A., and PUISIEUX, F., J. Microencapsulation, 1990, 7, (4), 555–565.
  • Polymeric biomaterials as enzyme and drug carriers. Part V: Polymeric matrixes as drug delivery systems. DUMITRIU, S., POPA, M., and DUMITRIU, M., J. Bioact. Compat. Polym., 1990, 5, (1), 89–127.
  • Computation of release kinetic mode LS for diloxanide furoate microcapsules. DUTTA, U. K., and PAL, T. K., Indian Drugs, 1990, 27, (12), 612–614.
  • Molecular control of vesicle aggregation and membrane fusion: hypotheses on bile vesicles. DUZGUNECS, N., Hepatology, 1990, 12, (3, Pt 2), 67S–74S.
  • Calcium phosphate precipitation in liposomal suspensions. EANES, E. D., Mater. Res. Soc. Symp. Proc., 174, (Mater. Synth. Util. Biol. Processes), 15–24.
  • Hemoglobin in a coacervate system. ECANOW, J., ECANOW, D., and ECANOW, B., Biomater., Arti f. Cells, Artil. Organs, 1990, 18, (2), 359–365.
  • Sustained release albumin microspheres containing antibacterial drugs: effects of preparation conditions on kinetics of drug release. EGBARIA, K., and FRIEDMAN, M., J. Controlled Release, 1990, 14, (1), 79–94.
  • Sustained in vitro activity of human albumin microspheres containing chlorhexidine dihydrochloride against bacteria from cultures of organisms that cause urinary tract infections. EGBARIA, K., and FlitEnmAN, M., Antimicrob. Agents Chemother., 1990, 34, (11), 2118–2121.
  • Liposomes as a topical drug delivery system. EGBARIA, K., and WEINER, N., Polym. Mater. Sci. Eng., 1990, 63, 59–63.
  • Decrease of liver energy charge ATP and glutathione at concomitant intraarterial administr-ation of adriamycin and degradable starch microspheres in rat. EL HAG, I. A., Roos, G., and STENRAM, U., Sel. Cancer Ther., 1990, 6, (3), 135–144.
  • Nutritional quality of a microencapsulated diet for Daphnia magna. Effects on reproduction, fatty acid composition, and midgut ultrastructure. ELENDT, B. P., Arch. Hydrobiol., 1990, 118, (4), 461–475.
  • Fusion of influenza hemagglutinin-expressing fibroblasts with glycophorin-bearing lipo-somes: role of hemagglutinin surface density. ELLENS, H., BENTZ, J., MASON, D., ZHANG, F., and WHITE, J. M., Biochemistry, 1990, 29, (41), 9697–9707.
  • Presence of endogenous cross-linking/bifunctional agents in gastrointestinal cavity as de-tected by transit of magnetic PEI microcapsules. ELLuL, A., POVEY, A., and O'NEILL, 1. K., Carcinogenesis, 1990, 11, (9), 1577–1582.
  • Retention and subsequent release of radioactivity from the incineration of wastes containing microspheres. EMERY, R. J., WATSON, J. E. JR, and SPRAU, D. D., Health Phys., 1990, 59, (6), 911–914.
  • Microencapsulation: a review. ENGBERG, B., Report, FOA-C-40270–4.4; 1989, 25 pp.
  • Thermodynamics of the binding of human apolipoprotein A-I to dimyristoylphosphatidyl-glycerol. EPAND, R. M., SEGREST, J. P., and ANANTHARAMAIAH. G. M., J. Biol. Chem., 1990, 265, (34), 20829–20.832.
  • Magnetic starch microspheres, biodistribution and biotransformation. A new organ-specific contrast agent for magnetic resonance imaging. FAHLVIK, A. K., HOLTZ, E., SCHROEDER, U., and KLAVENESS, J., Invest. Radiol., 1990, 25, (7), 793–797.
  • Antiproliferative activity of liposome-encapsulated transforming growth factor-beta against MDA-MB-435 human breast carcinoma cells. FAN, D., PRICE, J., SCHACKERT, H., SEM, C., WILMANNS, C., CHAKRABARTY, S., and FIDLER, I. J., Cancer Commun., 1989, 1, (6), 337–343.
  • Nasal administration of insulin using bioadhesive microspheres as a delivery system. FARRAJ, N. F., JOHANSEN, B. R., DAVIS, S. S., and ILLum, L., J. Controlled Release, 1990, 13, (2-3), 253–261.
  • Incorporation of WR 2721 and WR 1065 in nanoparticles: physicochemical and radioprotective studies. FATOME, M., LAVAL, J. D., and MASSOT, M., Acta Pharm. Technol., 1989, 35, (4), 238–242.
  • Particulate systems and polymers for in vitro and in vivo delivery of polynucleotides. FELGNER, P. L., Adv. Drug Delivery Rev., 1990, 5, (3), 163–188.
  • Transferring activity of liposomes conjugated to cholera toxin. FIACCAVENTO, R., BATTAGLIA, M., and TOMAS, I. M., Cell Biol. Int. Rep., 1990, 14, (Abstr. Suppl.), 253.
  • Systemic activation of macrophages by liposomes containing muramyltripeptide phos-phatidylethanolamine for therapy of cancer metastasis. FIDLER, I. J., J. Liposome Res., 1990, 1, (4), 461–471.
  • Interaction between cholesterol and phospholipid in hydrated bilayers. FINEAN, J. B., Chem. Phys. Lipids, 1990, 54, (3-4), 147–156.
  • Particles. FISCHER, H. W., Invest. Radiol., 1990, 25, (Suppl. 1.), S2–S6. polylactide microspheres as embolic agent. A preliminary study. FLANDROY, P., GRANDFILS, C., COLLIGNON, J., THIBAUT, A., NIHANT, N., BARRETTE, S., JEaomE, R., and TEYSSIE, P., Neuroradiology, 1990, 32, (4), 311–315.
  • Phospholipid order in gel- and fluid-phase cell-size liposomes measured by digitized video fluorescence polarization microscopy. FLORINE-CASTEEL, K., Biophys. J., 1990,57, (6), 1199–1215.
  • Phagocytosis of opsonized fluorescent microspheres by equine polymorphonuclear leuko-cytes. FOERSTER, R. J., and WOLF, G., Zentralbl. Veterinarmed. (B), 1990, 37, (7), 481–490.
  • Dermal drug delivery by liposome encapsulation clinical and electron microscopic studies. FOLDVARI, M., GESZTES, A., and MEZEI, M., 3. Microencapsulation, 1990, 7, (4), 479–490.
  • Glyceraldehyde-3-phosphate dehydrogenase promotes calcium dependent fusion of lipo-somes and secretion in permeabilized neutrophils. FRANCIS, J. W., STOEHR, S. J., MARGOLIS, D. I., BOXER, L. A., and SMOLEN, J. E., J. Cell. Biol., 1990, 111, (5, Pt 2), 77A.
  • Reconstitution of the solubilized p-opioid receptor coupled to a GTP-binding protein. FREY, E. A., GROSSE, M. E., and COTE, T. E., Eur. J. Pharmacol., Mol. Pharmacol. Sect., 1989, 172, (4-5), 347–356.
  • Interaction between Dotma liposomes CV and U937 cells and their isolated nuclei. FRIEND, D. S., DEBS, R. J., and DUZGUNES, N., J. Cell. Biol., 1990, 111, (5, Pt 2), 119A.
  • Blood glucose levels in diabetic rats after free and microencapsulated pancreatic islet transplantation. FRITSCHY, W. M., WOLTERS, G. H. J., and SCHILFGAARDE, R., Diabetologia, 1990, 33, (Suppl.), A42.
  • Chlorine 6-liposome interaction. Investigation by the methods of fluorescence spectroscopy and inductive resonance energy transfer. FROLOV, A. A., ZENKEVICH, E. I., GURINOVICH, G. P., and KOCHUBEYEV, G. A., 3. Photochem. Photobiol, B, 1990, 7, (1), 43–56.
  • Changes in NMR chemical shifts, and methacrylates induced by their interactions with the phospholipids and the phospholipid/cholesterol liposome system. FupsAwA, S., KADOMA, Y., and KOMODA, Y., Dent. Mater. J., 1990, 9, (1), 100–107.
  • Microcapsulated latent hardener 'Novacure' for one-part epoxy resin system. II. FUKUOKA, M., and YAMAMOTO, J., Kotingu ii/so, 1989, (184), 9–17.
  • Conformations of lysine-alanine random copolymers adsorbed on acidic phospholipid vesicles. FUKUSHIMA, K., INouE, T., and SHIMOZAWA, R., Fukuoka Daigaku Rigaku Shuho, 1989, 19, (2), 163–171.
  • Induction of tumoricidal activated macrophages by a liposome-encapsulated glycolipid trehalose 2,3,6'-trimycolate from Gordona aurantiaca. FURUKAWA, M., OHTSUBO, Y., SUGIMOTO, N., KATOH, Y., and Dom, Y., FEMS (Fed. Eur. Microbiol. Soc.) Microbiol. Immunol., 1990, 64, (2), 83–88.
  • Effect of liposome composition and other factors on the targeting of liposomes to experimental humors: biodistribution and imaging studies. GABIZON, A., PRICE, D. C., HUBERTY, J., BRESALIER, R. S., and PAPAHADJOPOULOS, D., Cancer Res., 1990, 50, (19), 6371–6378.
  • Evaluation of liposomes as drug carriers into the skin by one-dimensional EPR imaging. GABRIJELCIC, V., SENTJURC, M., and KRISTL, J., Int. 3. Pharm., 1990, 62, (1), 75–79.
  • Experimental study of the effect of liposomes on the hormonal activity of tyrosine aminotrans-ferase in the liver. GALAEV, Yu. V., ZAKREVSKII, V. I., and GoNcHARova, L. V., Vopr. Med. Khim., 1990, 36, (4), 6–7.
  • Possible applications of deactivation of triplet-excited state sensitized delayed fluorescence for studying liposome fusion. GASANOV, S. E., SALAKHUTDINOV, B. A., and ARIPOV, T. F., Biofizika, 1990, 35, (5), 879–880.
  • Preparation of controlled release anticancer agents I: 5-fluorouracil-ethyl cellulose micro-spheres. GHORAB, M. M., ZIA, H., and Luzzi, L. A., J. Microencapsulation, 1990,7, (4), 447–454.
  • Lack of responsiveness to glucose of microencapsulated islets of Langerhans after three weeks' implantation in the rat-influence of the complement. GIN, H., DUPUY, B., BAQUEY, A., BAQUEY, C., and DUCASSOU, D., J. Microencapsulation, 1990, 7, (3), 341–346.
  • Interactions of liposomes of various compositions with blood serum proteins. GOLUBCHIKOVA, N. A., SIDOROV, V. N., KREINES, V. M., and SHRAER, T. I., Vestn. Akad. Med. Nauk. SSSR, 1990, (6), 36–38.
  • Modification by diacylglycerols of phospholipid vesicles structure and physical properties. In NICOLAU, C. and CHAPMAN, D. (eds), Progress in Clinical and Biological Research, Vol. 343. Horizons in Membrane Biotechnology; 312 pp, Wiley-Liss, New York, NY, USA; publ. 1990, pp. 53–68.
  • The influence of physical characteristics of liposomes containing doxorubicin on their pharmacological behavior. GOREN, D., GABIZON, A., and BARENHOLZ, Y., Biochim. Biophys. Acta, 1990, 1029, (2), 285–294.
  • The exploration of a novel microencapsulated doxorubicin dosage form: an attempt to ameliorate drug toxicity. GRAHAM, K. D., Temple University, Philadelphia, PA, USA, Dissertation, 1990, 213 pp.
  • The immunoadjuvant action of liposomes: role of structural characteristics. GREGORIADIS, G., TAN, L., and XIAO, Q., NATO ASI Ser., Ser. A, 1989, 179, (Immunol. Adjuvants Vaccines), 79–84. Interactions of liposomes with human erythrocyte ghosts. GREIDZIAK, M., EHRKE, R., BAUST, G., TORCHILIN, V. P., and LASCH, J., Biomed. Biochim. Acta, 1990, 49, (4), 189–200.
  • Gel electrophoresis of micron-sized particles: a problem and a solution. GRIESS, G. A., and SERWER, P., Biopolymers, 1990, 29, (14), 1863–1866.
  • Use of proton-NMR to determine the distribution of lecithin between the micellar and vesicular phases in model bile. GROEN, A. K., GOLDHOORN, B. G., EGBERS, P. H. M., CHAMULEAU, R. A. F. M., TYTGAT, G. N. J., and BOVEE, W. M. M. J., J. Lipid Res., 1990, 31, (7), 1315–1321.
  • The effects of lipid composition on the binding of lasalocid A to small unilamellar vesicles. GRUNWALD, R., and PAINTER, G. R., Biochim. Biophys. Acta, 1990, 1027, (3), 245–252.
  • Vidarabine-loaded nanoparticles: a physicochemical study. GUISE, V., DROUIN, J. Y., BENOIT, J., MAHUTEAU, J., DUMONT, P., and COUVREUR, P., Pharm. Res., 1990, 7, (7), 736–741.
  • Application of regression analysis in the evaluation of tumor response following the administration of adriamycin either as a solution or via albumin microspheres to the rat. GUPTA, P. K., HUNG, C. T., and LAM, F. C., J. Pharm. Sci., 1990, 79, (7), 634–637.
  • Artificial blood: the future of blood transfusion? II. Blood substitutes other than hemoglobin solutions. GUYOT, M., and DOUTREMEPUICH, C., J. Pharm. Belg., 1990, 45, (3), 196–206.
  • Synthesis and use of artificial red cells. HAH JONG SIK, CHO ENG HAENG, and Kim Ku JA, Taehan Saengri Hakhoechi, 1990, 24, (1), 15–26.
  • Effects of intravenous infusions of commercial fat emulsions intralipid 10 or 20 percent on rat plasma lipoproteins: phospholipids in excess are the main precursors of lipoprotein-X-like particles. HApti, T., FEREZOU, J., and LUTTON, C., Biochim. Biophys. Acta, 1990, 1047, (2), 121–130.
  • Effect of drug substances on the microviscosity of lipid bilayer of liposomal membrane. HAN, S. K., KIM, J. S., LEE, Y. S., and Kim, M., Arch. Pharmacol. Res., 1990, 13, (2), 192–197.
  • Disulfide polymerizable phosphatidylcholines: characterization of membrane physical pro-perties and investigations of in vivo behavior. HANDEL, T. M., California Institute of Technology, Pasadena, CA, USA, Dissertation, 1989, 546 pp.
  • 5-Methylphenazinium methylsulfate mediates cyclic electron flow and proton gradient dissipation in chromaffin-vesicle membranes. HARNADEK, G. J., RIES, E. A., FARHAT, A., and Nws, D., J. Biol. Chem., 1999, 265, (30), 18135–18141.
  • Methodological aspects for free hormone estimation using microencapsulated antibody method-the effects of hormone binding protein on permeability of microcapsule membrane. HASHIMOTO, T., ISHIBASHI, K., and MATSUBARA, F., Ann. Nut. Med., 1990, 4, (1), 39–42.
  • Lipoprotein lipase immobilization onto polyacrolein microspheres. HAYASHI, T., and IKADA, Y., Biotechnol. Bioeng., 1990, 36, (6), 593–600.
  • Liposome technologies and production. Part 1. New dimensions in the chemistry of lipid membranes: potential of liposomes in cosmetic science. HAYWARD, J. A., and SMITH, W. P., Cosmet Toiletries, 1990, 105, (7), 47–48. 51–54.
  • Relationships between binding phagocytosis and membrane fusion of enveloped viruses. HAYWOOD, A. M. In NICOLAU, C. and CHAPMAN, D., (eds), Progress in Clinical and Biological Research, Vol. 343: Horizons in Membrane Biotechnology; 312 pp, Wiley-Liss, New York, NY, USA; publ. 1990, pp. 117–132.
  • Effect of liposome and cyclodextrin entrapment on retardation of glutathione decomposition of nitroimidazolyl sulfones. HEINDEL, N. D., EGOLF, R. A., and STEFELY, J. S., J. Pharm. Sc., 1990, 79, (10), 862–865.
  • A theoretical approach to describe monolayer-liposome lipid interaction. HERNANDEZ BORREEL, J., MAS, F., and Puy, J., Biophys. Chem., 1990, 36, (1), 47–55.
  • Stability of liposomes on long term storage. HERNANDEZ-CASELLES, T., VILLALAIN, J., and GOMEZ-FERNANDEZ, J. C., J. Pharm. Pharrnacol., 1990, 42, (6), 397–400.
  • In vivo hypertensive arterial wall uptake of radiolabeled liposomes. HODIS, H. N., AMARTEY, J. K., CRAWFORD, D. W., WICKHAM, E., and BLANKENHORN, D. H., Hypertension, 1990, 15, (6, Pt 1), 600–605.
  • Fluorescence assays to monitor membrane fusion: potential application in biliary lipid secretion and vesicle interactions. HOEKSTRA, D., Hepatology, 1990, 12, (3, Pt 2), 61S–66S.
  • Release of human serum albumin from poly(lactide-co-glycolide) microspheres. HORA, M. S., RANA, R. K., NUNBERG, J. H., TICE, T. R., GILLEY, R. M., and HUDSON, M. E., Pharm. Res., 1990, 7, (11), 1190–1194.
  • A preliminary double-blind cross-over trial of lipo-PGI2, a prostacyclin derivative in-corporated in lipid microspheres, in cerebral infarction. Hosm, K., and MIZUSHIMA, Y., Prostaglandins, 1990, 40, (2), 155–164.
  • Antitumor effect of liposome-entrapped adriamycin administered via the portal vein. Immo, T., YOTSUYANAGI, T., MIZUNO, I., AKAMO, Y., YAMAMOTO, T., SAITO, T., KURAHASHI, S., TANIMOTO, N., and YURA, J., Jpn. J. Cancer Res., 1990, 81, (10), 1052–1056.
  • Investigation of the nasal absorption of biosynthetic human growth hormone in sheep-use of a bioadhesive microsphere delivery system. ILLum, L., FARRAJ, N. F., DAVIS, S. S., JOHANSEN, B. R., and O'HAGAN, D. T., Int. J. Pharm., 1990, 63, (3), 207–211.
  • Liposome-entrapped superoxide dismutase reduces cerebral infarction in cerebral ischemia in rats. Immzum 1, S., WOOLWORTH, V., FISHMAN, R. A., and CHAN, P. H., Stroke, 1990, 21, (9), 1312–1317.
  • Interaction between 6,6'-diacyl-trehalose and phosphatidylcholine in liposomes: electron spin resonance studies. IMASATO, H., TABAK, M., SESSO, A., PROCOPIO, J., and IONEDA, T., Stud. Biophys., 1990, 135, (3), 181–190.
  • Identification by proteoliposome binding assay of type-selective herpes simplex virus-binding polypeptides in solubilized cellular plasma membrane. IsoNo, T., and SETO, A., Med. Sci. Res., 1990, 18, (20), 807–808.
  • Effect of the liposomal preparation aminophosphatide on erythrocyte lysis. Ivallova, N. N., PETROV, V. I., KAPLUN, A. P., SHVETS, V. I., SAVINA, L. S., MARTYNOVA, V. A., and MAKAROV, V. A., Vestn. Akad. Med. Nauk. SSR, 1990, (6), 38–40.
  • Binding of human endothelium to Ulex europaeus I-coated Dynabeads: application to the isolation of microvascular endothelium. JACKSON, C. J., GARRETT, P. K., NISSEN, B., and SCHRIEBER, L., J. Cell. Sci., 1990, 96, (Pt 2), 257–262.
  • Liposomes as drug carriers. JAGGI, M., and KHAR, R. K., Indian Drugs, 1990, 27, (8), 404-410. Microencapsulation using poly(m-lactic acid). III: Effect of polymer molecular weight on the release kinetics. JALIL, B., and NIXON, J. R., J. Microencapsulation, 1990, 7, (3), 357–374. Microencapsulation using poly(m-lactic acid). IV. Effect of storage on the microcapsule characteristics. JALIL, R., and Nntox, J. R., J. Microencapsulation, 1990, 7, (3), 375-383. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problemsassociated with preparative techniques and release properties. JALIL, R., and NIXON, J. R., J. Microencapsulation, 1990, 7, (3), 297–325.
  • The induction of lipid peroxidation in liposomal membrane by ultrasound and the role of hydroxyl radicals. JANA, A. K., AGARWAL, S., and CHATTERJEE, S. N., Radiat. Res., 1990, 124, (1), 7–14.
  • Suspension polymerization of 2-hydroxyethyl methacrylate in the presence of polymeric diluents: a novel route to spherical highly porous beads for biomedical applications. JAYAKRISHNAN, A., and THANOO, B. C., J. Biomed. Mater. Res., 1990, 24, (7), 913–927.
  • Preparation and evaluation of radiopaque hydrogel microspheres based on PHEMAfiothalamic acid and PHEMAfiopanoic acid as particulate emboli. JAYAKRISHNAN, A., THANOO, B. C., RATHINAM, K., and MOHANTY, M., J. Biomed. Mater. Res., 1990, 24, (8), 993–1004.
  • In vitro study of sulfadimidine release from granular powders and microcapsules. JHELJAsKovA, J., Pharmazie, 1990, 45, (7), 532–533.
  • Attenuation of toxicity of adriamycin by entrapment in liposome. jThino, T., YAMADA, M., KIKUCHI, N., Toup-0, H., and NOMURA, M., .1. Toxicol. Sci., 1990, 15, (3), 220.
  • Enhancement of interleukin-2 activity by liposomes. JOFFRET, M. L., MORGEAUX, S., LACLERC, C., 0TH, D., ZANETTI, C., SUREAU, P., and PERRIN, P., Vaccine, 1990, 8, (4), 385–389.
  • Interactions of free and liposomal amphotericin B with renal proximal tubular cells in primary culture. Jois, V., SAINT-JULIEN, L., CARBON, C., and YENI, P., J. Pharmacol. Exp. Ther., 1990, 255, (1), 17–22.
  • Effect of microencapsulated acetylsalicylic acid on glycosylation of human serum proteins in vitro. JURETIC, D., CEPELAK, I., JALSENJAK, V., ZANIC, G., LIPOVAC, K., and JALSENJAK, I., Int. J. Pharm., 1990, 61, (3), 219–223.
  • Distribution studies of liposome-encapsulated glutathione administered to the lung. JURIMA ROMET, M., BARBER, R. F., DEMEESTER, J., and SHEK, P. N., Int. J. Pharm., 1990,63, (3), 227–235.
  • Gadolinium-labeled liposomes containing amphipathic agents for magnetic resonance imaging. KABALKA, G. W., DAVIS, M. A., BUONOCORE, E., HUBNER, K., HOLMBERG, E., and HUANG, L., Invest. Radiol., 1990, 25, (Suppl. 1), S63–S64.
  • Characterization of Leishmania major antigen-liposomes that protect BALB/c mice against cutaneous leishmaniasis. KAHL, L. P., LELCHUK, R., SCOTT, C. A., and BEESLEY, J., Infect. Immun., 1990, 58, (10), 3233–3241.
  • Membrane fluidity changes of liposomes in response to various odorants; complexity of membrane composition and variety of adsorption sites for odorants. KASHIWAYANAGI, M., SUENAGA, A., ENOMOTO, S., and KURIHARA, K., Biophys. J., 1990, 58, (4), 887–896.
  • Effervescent granule based proliposomes of ibuprofen. KATARE, 0. P., VYAS, S. P., and DIXIT, V. K., J. Microencapsulation, 1990, 7, (4), 455–462.
  • Effect of amphipathic peptides containing an amino acid with long alkyl side chain on phospholipid membrane. KATO, T., ONO, S., AGAWA, Y., LEE, S., AOYAGI, H., OHNO, M., and NISHINO, N., Pept. Chem., 1990, 27, 149–152.
  • Preparation of nicardipine hydrochloride nanosphere and bioavailability in dogs. KATO, Y SUGIMOTO, Y., INouE, H., MARUYAM, K., and WAGATSUMA, N., Yakuzaigaku, 1990, 50, (3), 225–229.
  • Combination therapy of C1300 murine neuroblastoma with IL-2 liposomes anti-GD2 mono-clonal antibody and cyclophosphamide. KATSANIS, E., OCHOA, A. C., BAUSERO, M. A., LOEFFLER, C. M., and ANDERSON, P. M., J. Cell. Biochem. Suppl., 1990, (14, Pt B), 97.
  • Preparation and characterization of novel hydrogel microspheres. KAWAGUCHI, H., KAWAHARA, M., YAMADA, Y., and OHTSUKA, Y Polym. Mater. Sci. Eng., 1990, 62, 417.
  • Role of the membrane skeleton proteins of erythrocyte ghosts in the function of membrane enzymes. KAZENNOV, A. M., MASLOVA, M. N., and SHALABODOV, A. D., Dokl. Akad. Nauk. SSSR, 1990, 312, (1), 223–226.
  • Liposomes as drug delivery systems to the lung. KELLAWAY, I. W., and FARR, S. J., Adv. Drug. Delivery Rev., 1990, 5, (1-2), 149–161.
  • Differential effects of free and liposome encapsulated amikacin on the survival of Myco-bacterium avium complex in mouse peritoneal macrophages. KESAVALU, L., GOLDSTEIN, J. A., DEBS, R. J., DUZGUNES, N., and GANGADHARAM, P. R., Tubercle, 1990, 71, (3), 215–217.
  • Determination of retinal blood velocity with respect to the cardiac cycle using laser-triggered release of liposome-encapsulated dye. KHOOBEHI, B., ALY, 0. M., SCHUELE, K. M., STRADTMANN, M. 0., and PEYMAN, G. A., Lasers Surg. Med., 1990, 10, (5), 469–475.
  • Incorporation of human liver and placental alkaline phosphatases into liposomes and membranes is via phosphatidylinositol. KinN, L., RUTKOWSKI, D., and STINSON, R. A., Biochem. Cell Biol., 1990, 68, (9), 1112–1118.
  • Receptor-independent delivery of interferon to intracellular target molecules by encapsul-ation of interferon into liposomes. KILLION, J. J., CFIERNAJOVSKY, Y., and FIDLER, I. J., J. Interferon. Res., 1990, 10, (Suppl. 1), S74.
  • Protective effect of oral liposomal superoxide dismutase on oxygen toxicity in prednisone-treated rat lung. KIM, S. Y., BACK, K. J., and LEE, H. S., Korean Biochem. J., 1990,23, (3), 322–327.
  • Direct cerebrospinal fluid delivery of an antiretroviral agent using multivesicular liposomes. KIM, S., SCHEERER, S., GEYER, M. A., and HOWELL, S. B., J. Infect. Dis., 1990, 162, (3), 750–752.
  • Some determinants of morphology and release rate from poly(L-lactic acid) microspheres. KISHIDA, A., DRESSMAN, J. B., YOSHIOKA, S., Aso, Y., and TAKEDA, Y., J. Controlled Release, 1990, 13, (1), 83–89.
  • Liposomal MTP-PE for the adjuvant therapy of osteosarcoma. KLEINERMAN, E. S., and JAFFE, N., Prog. Clin. Biol. Res., 1990, 343, (Horiz. Membr. Biotechnol.), 263–279.
  • Amphipathic polyethylene glycols effectively prolong the circulation time of liposomes. KLIBANOV, A. L., MARUYAMA, K., TORCHILIN, V. P., and HUANG, L., FEBS Lett., 1990, 268, (1), 235–237.
  • Phospholipid vesicles (liposomes) for drug delivery systems. KOBAYASHI, T., and OKU, N., Bio. Ind., 1990, 7, (7), 508–516.
  • Cation transport by modified dibenzo-18-crown-6 through lecithin liposomal membrane. KOBUKE, Y., and YAMAMOTO, J., Bioorg. Chem., 1990, 18, (3), 283–290.
  • Thermochemical analysis on the state of phospholipid liposomes as revealed by high sensitivity differential scanning calorimetry. KODAMA, M., Yukagaku, 1990, 39, (8), 530–537.
  • Application of a drug delivery system using lipid microspheres in steroid eye drops. KOMATSU, A., TANE, S., MIZUSHIMA, Y., and INAFUKU, Y Folio Ophthalmol. Jpn., 1990, 41, (4), 828–832.
  • Application of a drug delivery system using lipid microspheres in non-steroidal eye drops. KOMATSU, A., TANE, S., MIZUSHIMA, Y., and OBA, H., Folia Ophthalmol. Jpn., 1990, 41, (3), 618–623.
  • Polymers as stabilizer of phospholipid vesicles. KoNoo, T., KATO, A., FUKUDA, K., ATSUTA, Y MURAMATSU, N., and OHSHIMA, H., Polym. Mater. Sci. Eng., 1990, 63, 717–719.
  • The effects of phosphatidylethanolamine and phosphatidylglycerol headgroups on bilayer dynamics: a slow-motion ESR study. KORSTANJE, L. J., EIKELENBOOM, K. A., VAN DER REIJDEN, C. S., VAN GINKEL, G., and LEVINE, Y. K., Chem. Phys. Lipids, 1990, 55, (2), 123–132.
  • Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in Psoriasis vulgaris. KORTING, H. C., ZIENICKE, H., SCIAEFER-KORTING, M., and BRAUN-FALCO, 0., Eur. J. Clin. Pharmacol., 1990, 39, (4), 349–352.
  • Novel liposomes for efficient transfection of beta-galactosidase into COS-1 cells. KOSHIZAKA, T., HAYASHI, Y., and YAGI, K., J. Clin. Biochem. Nutr., 1989, 7, (3), 185–192.
  • Enhanced in vitro activity of liposome-trapped penicillin-G against Pseudomonas aeruginosa. KOTSIFAKI, H., TZOUVELEKIS, L. S., PANAGIOTIDOU, G., VATOPOULOS, A. C., ECONOMOPOULOU, C., and LEGAKIS, N. J., J. Chemother., 1990, 2, (2), 82–86.
  • Evaluation of microcapsules prepared by the powder bed method using purified water as solvent. KOYAMA, I., SHIMANO, K., MAKABE, E., OZAWA, V., and GOTO, S., Yakuzaigaku, 1990, 50, (2), 83–88.
  • Dissolution test in syrup and taste test of microcapsules prepared by the powder bed method using acetone as solvent. KOYAMA, I., SHIMANO, K., MAKABE, E., OZAWA, Y., and GOTO, S., Yakuzaigaku, 1990, 50, (1), 1–7.
  • Anti-inflammatory effects of liposomes. KREINES, V. M., MECNIKOVA, V. M., MARGOLIN, IA. M., MECIANTSEVA, L. P., GLADSHTEIN, A. I., and ANDRIASIAN, B. A., Vestn. Akad. Med. Nauk. SSSR, 1990, (6), 44–47.
  • Preparation and evaluation of sterically stabilized liposomes: colloidal stability, serum stability, macrophage uptake, and toxicity. KRONBERG, B., DAHLMAN, A., CARLFORS, J., KARLSSON, J., and ARTURSSON, P., J. Pharm. Sci., 1990, 79, (8), 667–671.
  • Urinary bladder blood flow. I. Comparison of clearance of locally injected 99m technetium pertechnate and radioactive microsphere technique in dogs. KROYER, K., BuLow, J., NIELSEN, S. L., and KROMANN ANDERSON, B., Urol. Res., 1990, 18, (3), 223–226.
  • Colorimetric liposome lysis for assay of anti-streptolysin 0 antibody. KUBOTSU, K., Usnto, I., YOSHIKAWA, K., KIDA, M., ISHIKAWA, K., MATSUURA, S., and SAKURABAYASHI, I., ClM. Chem., 1990, 36, (10), 1747–1749.
  • Reconstruction of purified calcium, magnesium-ATPase from the myometrium sarcolemma into liposomes and its catalytic properties. KURSKII, M. D., SLINCHENKO, N. N., and LIUBAKOVSKAIA, L. A., Ukr. Biokhim. Zh., 1990, 62, (3), 66–71.
  • Ternary complexes DNA-liposomes-magnesium investigation by freeze-etching technique: new nucleus pore model. KUVICHKIN, V. V., Cell. Biol. Int. Rep., 1990,14, (Abstr. Suppl.), 194. Isothermal compressibility of phospholipid vesicles: a new fast experimental approach. LA
  • ROSA, C., and GRASSO, D., Nuovo Cimento Soc. Ital. Fir., D, 1990, 12D, (9), 1213–1218.
  • Study of shellac glycerol esters as microencapsulating materials II. Quantitative correlation between physico-chemical properties and release characteristics. LABHASETWAR, V. D., PURANIK, P. K., and DORLE, A. K., J. Microencapsulation, 1990, 7, (4), 553–554.
  • Inhibition of autoxidation of egg yolk phosphatidylcholine in homogeneous solution and in liposomes by oxidized ubiquinone. LANDI, L., FIORENTINI, D., STEFANELLI, C., PASQUALI, P., and PEDULLI, G. F., Biochim. Biophys. Acta, 1990, 1028, (3), 223–228.
  • New methods of drug delivery. LANCER, R., Science, 1990, 249, (4976), 1527–1533.
  • Fusion of simian immunodeficiency virus with liposomes and erythrocyte ghost membranes: effects of lipid composition, pH and calcium. LARSEN, C. E., ALFORD, D. R., YOUNG, L. J., McGaAw, T. P., and DUZGUNECS, N., J. Gen. Virol., 1990, 71, (Pt 9), 1947–1955.
  • Liposomes. LASIC, D. D., and MARTIN, F. J., Farm. Vestn. (Ljubljana), 1989, 40, (4), 197–208. Enhancement of hyperthermic damage on M13 melanoma cells by liposome pretreatment.
  • LAUDONIO, N., MARCOCCI, L., ARANCIA, G., CALCABRINI, A., DEL BUFALO, D., GRECO, C., ZUPI, G., MAVELLI, I., PEDERSEN, J. Z., et al., Cancer Res., 1990, 50, (16), 5119–5126.
  • Liposomes in dermatological preparations. Part II. LAUTENSCHLAEGER, H., Cosmet Toiletries, 1990, 105, (7), 63–66. 69–72.
  • Liposomes-a cosmetic and /or pharmaceutical raw material? LAUTENSCHLAEGER, H., Parfuem Kosmet, 1990, 71, (9), 612–613. 616.
  • Liposomes in dermatological preparations. Part. LAUTENSCHLAEGER, H., Cosmet Toiletries, 1990, 105, (5), 89–90. 92–94. 96.
  • Simplified method of making alginate-polylysine microcapsules for hybridoma cell culture using RPM 1640 medium. LEE, G. M., and PALSSON, B. 0., Biotechnol. Tech., 1990, 4, (5), 341–344.
  • Binding and endocytosis of liposomes enhanced by specific phospholipid headgroups and modulated by surface charge density. LEE, K. D., HONG, K., FRIEND, D. S., and PAPHADJOPOULS, D., J. Cell. Biol., 1990, 111, (5, Pt 2), 191A.
  • Influence of different liposomal formulations on pharmacokinetics of encapsulated bupivacaine. LEGROS, F., Luo, H., BOURGEOIS, P., LAFONT, N., and BOOGAERTS, J., Anesthesi-ology, 1990, 73, (3A), A851.
  • Intestinal absorption of a peptide drug from bioadhesive microspheres. LEHR, C. M., BOUWSTRA, J. A., TUKKER, J. J., DE BOER, A. G., VERHOEF, J. C., and JUNGINGER, H. E., J Controlled Release, 1990, 13, (2-3), 311.
  • Intestinal transit of bioadhesive microspheres in an in situ loop in the rat-a comparative study with copolymers and blends based on poly(acrylic acid). LEHR, C. M., BOUWSTRA, J. A., TUKKER, J. J., and JUNGINGER, H. E., J. Controlled Release, 1990, 13, (1), 51–62.
  • Targeted liposomes and intracellular delivery of macromolecules. LESERMAN, L., MACHY, P., LEONETTI, J. P., MILHAUD, P. G., DEGOLS, G., and LEBLEU, B., Prog. Clin. Biol. Res., 1990, 343, (Horiz. Membr. Biotechnol.), 95–102.
  • Phospholipid vesicle solubilization and reconstitution by detergents. Symmetrical analysis of the two processes using octaethylene glycol mono-N-dodecyl ether. LEVY, D., GuLix, A., SEIGNEURET, M., and RIGAUD, J. L., Biochemistry, 1990, 29, (40), 9480–9488.
  • Evidence for proton countertransport by the sarcoplasmic reticulum calcium-ATPase during calcium transport in reconstituted proteoliposomes with low ionic permeability. LEVY, SEIGNEURET, M., BLUZAT, A., and RIGAUD, J. L., J. Biol. Chem., 1990, 265, (32), 19524-19534. Microcapsules prepared through interfacial crosslinking of starch derivatives. LEVY, M. C., and ANDRY, M. C., Int. J. Pharm., 1990, 62, (1), 27–35.
  • Preparation of spherical zirconia particles by controlled coagulation in zirconia sols. Li MAOQIANG, and MESSING, G. L., Ceram. Trans., 1990, 12, (Ceram. Powder Sci. 3), 129–136.
  • Biodegradable polymeric matrix for long-acting and zero-order release drug delivery systems. Li You XIN, and FENG XIN DE, Makromol. Chem. Macromol. Symp., 1990, 33, (Symp. Mol. Des. Funct. Polym., 1989), 253–264.
  • Gastric protective activity of microemulsions containing phospholipid and neutral lipid. LICHTENBERGER, L. M., ROMERO, J. J., KAO, Y. C. J., and DIAL, E. J., Dig. Dis. Sci., 1990, 35, (8), 1035.
  • Liposome encapsulated hemoglobin: stabilization, encapsulation, and storage. LIGLER, F. S., STRATTON, L. P., and RUDOLPH, A. S., Prog. Clin. Biol. Res., 1989, 319, (Red Cell), 435–455. Microencapsulation of pancreatin and its structure. LIN, C. W., and CHEN, P. F., J. Clin. Agric.
  • Chem. Soc., 1990, 28, (2), 112–124.
  • Bioavailability and pharmacokinetics of new sustained-release theophylline microcapsules after single and multiple oral administration. LIN, S. Y., WANG, S. R., and CHANG, H. N., Curr. Thee. Res. Clin. Exp., 1990, 48, (3), 524–534.
  • Asymmetric reconstitution of the erythrocyte anion transport system in vesicles of different curvature: implications for the shape of the band 3 protein. LINDENTHAL, S., SCHEURING, U., RUE, H., KOJRO, Z., HAASE, W., PETRASCH, P., and SCHUBERT, D., Z. Naturforsch. Sect. C. Biosc., 1990, 45, (9-10), 1021–1026.
  • Biodegradable polyesters for the controlled delivery of vaccines. LINHARDT, R. J., WANG, H. T., FI.ANAGAN, D. R., SCHMITT, E., and PALMER, H., Polym. Mater. Sci. Eng., 1990, 63, 39–42.
  • Liposome flow injection immunoassay: implications for sensitivity, dynamic range, and antibody regeneration. LOCASCIO BROWN, L., PLANT, A. L., HORVATH, V., and DURST, R. A., Anal. Chem., 1990, 62, (23), 2587–2593.
  • Optimized procedures for the coupling of proteins to liposomes. LOUGHREY, H. C., CHOI, L. S., CuLtis, P. R., and BALLY, M. B., J. Immunol. Methods, 1990, 132, (1), 25–35.
  • Protein-liposome conjugates with defined size distributions. LOUGHREY, H. C., WONG, K. F., CHOI, L. S., CULLIS, P. R., and BALLY, M. B., Biochim. Biophys. Acta, 1990, 1028, (1), 73–81. Targeted liposomes. LOUGHREY, H. C., University of British Columbia, Vancouver, BC, Canada.
  • Dissertation, 1989, no pagination.
  • Specific accumulation of cholesterol-rich liposomes in the inflammatory tissue of rats with adjuvant arthritis. LOVE, W. G., Amos, N., KELLAWAY, I. W., and WILLIAMS, B. D., Ann. Rheum. Dis., 1990, 49, (8), 611–614.
  • Scintigraphic imaging of inflamed tissue using serum-stable technetium-99m liposomes. LOVE, W. G., FARE, S., KELLAWAY, I. W., and WILLIAMS, B. D., Br. J. Rheumatol., 1990, 29, (Abstr. Suppl. 2), 55.
  • Liposome chromatography: a new mode of separation using lipid bilayer. LUNDAHL, P., YANG, Q., and TAKAGI, T., Tanpakushitsu Kakusan Koso, 1990, 35, (11), 1983–1998.
  • Arguments for a new formulation of liposomal amphotericin B: an historical perspective. MACKANESS, G. B., J. Liposome Res., 1990, 1, (4), 521–528.
  • High-resolution printing by laser addressing of microencapsulated dyes. MADER, G., MEIXNER, H., and KLUG, G., J. Imaging Sci., 1990, 34, (5), 213–216.
  • Latex nanosphere delivery system (LNDS): novel nanometer-sized carriers of fluorescent dyes and active agents selectively target neuronal subpopulations via uptake and retrograde transport. MADISON, R., MACKLIS, J. D., and THIES, C., Brain Res., 1990, 522, (1), 90–98.
  • A microcapsule self-regulating delivery system for insulin. MAKING, K., MACK, E. J., OKANO, T., and Kim, S. W., J. Controlled Release, 1990, 12, (3), 235–239.
  • Controlled release indomethacin microspheres prepared by using an emulsion solvent-diffusion technique. MALAMATARIS, S., and AVGERINOS, A., Int. J Pharm., 1990, 62, (2-3), 105–111.
  • Non-thermal effects of ultrasound on erythrocyte ghosts at 77K. MALININ, G. I., HIMBERGER, D. E., HORNICEK, F. J., Lo, H. K., and MAYER, W. G., Stud. Biophys., 1990, 135, (2), 83–91.
  • The electrogenic stage associated with the reduction of the secondary quinone acceptor in proteoliposomes containing photosynthetic reaction centers. MAMEDOV, M. D., SHINKAREV, V. P., SEMENOV, A. Y., and YERKHOVSKII, M. I., Biol. Membr., 1990, 7, (7), 730–735.
  • Phosphatidylinositol liposomes increase calcium uptake and tissue plasminogen activator secretion by fetal human lung fibroblasts. MARAN, R., KADOURI, A., FLORU, S., GELVAN, A., and COHEN, A. M., Biochem. Med. Metab. Biol., 1990, 44, (2), 106–113.
  • Effect of probucol on the lipid composition of blood plasma, erythrocyte ghosts and liver membranes in mice. MARKOVSKA, T., NEICHEVA, T., MOMCHILOVA PANKOVA, A., KUMANOV, K., and INFANTE, R., Int. J. Biochem., 1990, 22, (9), 1009–1013.
  • Development of liposomes for aerosol delivery: recent preclinical and clinical results. MARTIN, F., .1. Liposome Res., 1990, 1, (4), 417–439.
  • Yeast K1 killer toxin forms ion channels in sensitive yeast spheroplasts and in artificial liposomes. MARTINAC, B., ZHU, H., KUBALSKI, A., ZHOU, X., CULBERTSON, M., BUSSEY, H., and KUNG, C., Proc. Natl. Acad. Sci. USA, 1990, 87, (16), 6228–6232.
  • Distributed feedback oscillation in ordered colloidal suspensions of polystyrene micro-spheres. MARTORELL, J., and LAWANDY, N. M., Opt. Commun., 1990, 78, (2), 169–173.
  • Characterization in vivo immunoliposome targeting to pulmonary endothelium. MARUYAMA, K., HOLMBERG, E., KENNEL, S. J., KLIBANOV, A., TORCHILIN, V. P., and HUANG, L., J. Pharm. Sci., 1990, 79, (11), 978–984.
  • Liposomal drug delivery system. MARUYAMA, K., KENNEL, S. J., and HUANG, L., Polym Prepr. (Am. Chem. Soc., Div. Polym. Chem.), 1990, 31, (2), 159–160.
  • Lipid composition is important for highly efficient target binding and retention of im-munoliposomes. MURUYAMA, K., KENNEL, S. J., and HUANG, L., Proc. Natl. Acad. Sci. USA, 1990, 87, (15), 5744–5748.
  • Prolongation of anesthetic effect by epidural administration of liposomal-encapsulated lidocaine in dogs. MASHIMO, T., INAGAKI, Y., UCHIDA, I., PAK, M., and YOSHIYA, I., Anesthesiology, 1990, 73, (3A), A798.
  • Morphology of polyanhydride microsphere delivery systems. MATHIOWITZ, E., KLINE, D., and LANGER, R., Scanning Microsc., 1990, 4, (2), 329–340.
  • Acid resistance of beta-galactosidase encapsulated in liposomes. MATSUZAKI, M., Rakuno Kagaku, Shokuhin no Kenkyu, 1989, 38, (6), A271–A275.
  • Comparison of free, and liposome encapsulated doxorubicin tumor drug uptake and antitumor efficacy in the SC115 murine mammary tumor. MAYER, L. D., BALLY, M. B., CuLLis, P. R., WILSON, S. L., and EMERMAN, J. T., Cancer Lett., 1990, 53, (2-3), 183–190.
  • Strategies for optimizing liposomal doxorubicin. MAYER, L. D., BALLY, M. B., and Cutus, P. R., J. Liposome Res., 1990, 1, (4), 473–490.
  • Effects of treatment with microencapsulated monosialoganglioside GM1 on cortical and striatal acetylcholine: release in rats with cortical devascularizing lesions. MAYSINGER, D., HERRERA MARSCHITZ, M., UNGERSTEDT, U., and CUELLO, A. C., Neurosci. Lett., 1990, 118, (20), 252–256.
  • Preparation and in vivo effect of microencapsulated cholinotoxin. MAYSINGER, D., ZORC, B., BUTULA, I., and JALSENJAK, I., Int. J. Pharm., 1990, 63, (2), 149–154.
  • Enhancement of the protective efficacy of inactivated influenza A virus vaccine in aged mice by IL-2 liposomes. MBAWIJIKE, I. N., WYDE, P. R., and ANDERSON, P. M., Vaccine, 1990, 8, (4), 347–352.
  • Retention of topical liposomal formulations on the cornea. MCCALDEN, T. A., and LEVY, M., Experientia, 1990, 46, (7), 713–715.
  • Aerosol delivery of liposome metaproterenol sulfate. MCCALDEN, T. A., PORTER, J., and KAMAREI, A., Proc. West. Pharmacol. Soc., 1990, 33, 171–173.
  • Liposomal drug delivery to the lung. MCCALDEN, T. A., and RADHAKRISHNAN, R., EU?' . J. Pharmacol., 1990, 183, (6), 2133–2134.
  • Antioxidant activity of probucol and its effects on phase transitions in phosphatidylcholine liposomes. MCLEAN, L. R., and HAGAMAN, K. A., Biochim. Biophys. Acta, 1990, 1029, (1), 161–166.
  • Feasibility of cellular microencapsulation technology for evaluation of anti-human immuno-deficiency virus drugs in vivo. MCMAHON, J., SCHMID, S., WEISLOW, 0., STINSON, S., CAMALIER, R., GULAKOWSKI, R., SHOEMAKER, R., KISER, R., DYKES, D., HARRISON, S., et al., J. Natl. Cancer Inst., 1990, 82, (22), 1761–1765.
  • Liposome-encapsulated amphotericin B in the treatment of experimental murine candidiasis. MIYAZAKI, T., KOHNO, S., KAKU, M., KOGA, H., and YAMAGUCH t, K., Tohoku J Exp. Med., 1990, 161, (4), 273–282.
  • Lipid microspheres and lecithinized polymer for drug delivery systems. MIZUSHIMA, Y., and IGARASHI, R., Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.), 1990, 31, (2), 161–162.
  • Formulation parameters affecting the preparation and properties of microencapsulated ion-exchange resins containing theophylline. MOLDENHAUER, M. G., and NAIRN, J. G., J. Pharm. Sci., 1990, 79, (8), 659–666.
  • Purification and partial characterization of extracellular liposomes isolated from the hyper-lipidemic rabbit aorta. MORA, R., S1MIONESCU, M., and SIMIONESCU, N., J. Lipid Res., 1990,31, (10), 1793–1808.
  • In vitro activation of turnoricidal properties of human monocytes by beta-carotene en-capsulated in liposomes. MORIGUCHI, S., and Ktsmr.to, Y Nutr. Res., 1990, 19, (8), 837–846.
  • Intravitreal drug delivery by microspheres of biodegradable polymers. MORITERA, T., OGURA, Y., HONDA, Y., WADA, R., HYON, S. H., and IKADA, Y., Nippon Ganka Gakkai Zasshi, 1990,94, (5), 508–518.
  • A receptor and G-protein-regulated polyphosphoinositide-specific phospholipase C from turkey erythrocytes. II. P2Y-purinergic receptor and G-protein-mediated regulation of the purified enzyme reconstituted with turkey erythrocyte ghosts. MORRIS, A. J., WALDO, G. L., DOWNES, C. P., and HARDEN, T. K., J. Biol. Chem., 265, (23), 13508–13514.
  • Effect of spermine on association of protein kinase C with phospholipid vesicles. MORUZZI, M.
  • S., MONTI, M. G., PICCININI, G., MARVERTI, G., and TADOLINI, B., Life Sci., 47, (16), 1475–1482. In vitro model for the degradation of alkylcyanoacrylate nanoparticles. MULLER, R. H., LHERM, C., HERBORT, J., and COUVREUR, P., Biomaterials, 1990, 11, (8), 590–595.
  • Antimumor activity against human gastric cancers of sulfatide-inserted liposomes containing entrapped adriamycin. NAGATA, J., YAMAUCHI, M., TAKAGI, H., KOJIMA, N., HAYASHI, Y:, and YAGI, K., J. Clin, Biochem. Nutr., 1990, 8, (2), 111–120.
  • Bile salt-induced disintegration of egg phosphatidylcholine liposomes: a kinetic study based on turbidity changes. NAGATA, M., YOTSUYANAGI, T., and IKEDA, K., Chem. Pharm. Bull., 1990, 38, (5), 1341–1344.
  • Influence of timing of administration of liposome-encapsulated superoxide dismutase on its prevention of acetaminophen-induced liver cell necrosis in rats. NAKAE, D., Yospu H., YAMAMOTO, K., MARUYAMA, H., KINUGASA, T., TAKASHIMA, Y., DENDA, A., and KONISHI, Y Acta Pathol. Jpn., 1990, 40, (8), 568–573.
  • Liposomes and other fine particle preparations. 2. Fine particle preparations other than liposomes. NAKANO, M., Nippon Yakuzaishikai Zasshi, 1990, 42, (2), 129–135.
  • Glucuronate-modified liposomes with prolonged circulation time. NAMBA, Y., SAKAKIBARA, T., MASADA, M., ITO, F., and OKU, N., Chem. Pharm. Bull., 1990, 38, (6), 1663–1666.
  • Tumor cell growth inhibition by liposome-encapsulated aromatic polyamidines. NASTRUZZI, C., GAMBAR1, R., MENEGATTI, E., WALDE, P., and Luis', P. L., J. Pharm. Sci., 1990, 79, (8), 672–677.
  • Development of a new type of influenza subunit vaccine made by muramyldipeptide-liposome enhancement of humorsl and cellular immune responses. NEROME, K., YOSHIOKA, Y., ISHIDA, M., OKUMA, K., OKA, T., KATAOKA, T., INouE, A., and OYA, A., Vaccine, 1990, 8, (5), 503–509.
  • Trends in the development of research in the field of liposomes (review of patent literature). NESYTOVA, N. Tv., PALEVA, N. S., IL'INA, E. V., SHENK, P., BENDAS, F., and NUN, P., Vestn. Akad. Med. Nauk. SSSR, 1990, (6), 8–19.
  • Serum albumin beads possessing slow-release properties for vaccines. NEWMAN, J. F., Adv. Biotechnol. Processes, 1990, 14, 129–146.
  • Uptake of instilled radiolabeled lamellar bodies from alveolar compartment of the rat. NICHOLAS, T. E., BARR, H. A., POWER, J. H., and JONES, M. E., Am. J. Physiol., 1990, 259, (4, Pt 1), L238–L246.
  • CD4 inserted in red blood cell membranes or reconstituted in liposome bilayers as a potential therapeutic agent against AIDS. NICOLAU, C., TOSI, P. F., ARVINTE, T., MOUNEIMNE, Y., CTIDD, A., SNEED, L., MADOULET, C., SCHULZ, B., and BARHOUMI, R., Frog. Clin. Biol. Res., 343, (Horiz. Membr. Biotechnol.), 147–177.
  • Influence of microencapsulation conditions on physicotechnological properties of micro-capsules. N1KOLAEV, A. S., Farmatsiya (Moscow), 1990, 39, (5), 31–35.
  • Single-cell entrapment and microcolony development within uniform microspheres amen-able to flow cytometry. NIR, R., LAMED, R., GUETA, L., and SAHAR, E., Appl. Environ. Microbiol., 1990, 56, (9), 2870–2875.
  • Fusion of enveloped viruses with cells and liposomes activity and inactivation. NIR, S., DUZGUNES, N., PEDROSO DE LIMA, M. C., and HOEKSTRA, D., Cell. Biophys., 1990, 17, (2), 181–201.
  • Increasing packing density of hydrated dipalmitoylphosphatidylcholine unilamellar vesicles induced by trehalose. NISHIWAKI, T., SAKURAI, M., INOUE, Y., CHUJO, R., and KOBAYASHI, S., Chem. Lett., 1990, (10), 1841–1844.
  • The use of circular dichroism active phospholipid to study bacteriorhodopsin-lipid interac-tion: effects of lipid to protein ratio and crosslinkings of lysine residues. NISHIYA, T., and MAEDA, A., Chem. Phys. Lipids, 1990, 55, (2), 115–122.
  • Nebulization of liposomes. I. Effects of lipid composition. NIVEN, R. W., and SCIIREIER, H., Pharm. Res., 1990, 7, (11), 1127–1133.
  • Electrooptical properties of films consisting of nematic liquid crystals and connected polymer microspheres. NOMURA, H., Suzum, S., and ATARASHI, Y., J. Appl. Phys., 1990, 68, (6), 2922–2926.
  • Liposome-delivered glucose-6-phosphate stimulates insulin biosynthesis in isolated rat islets. OBERG, C., and WELSH, N., Diabetologia, 1990, 33, (Suppl.), A93.
  • Therapy of murine hepatic metastases using CD3-LAK cells and 1L2-liposomes. OCHOA, A. C., LOEFFLER, C., LEONARD, A., and ANDERSON, P.M., J. Cell. Biochem., Suppl., 1990, (14, Pt B), 100.
  • Analysis of the molecular requirements for T cell recognition and activation by using IA-containing lipid vesicles and stopped-flow fluorometry. ODAKA, C., UTSUNOMIYA, N., NAKANISHI, M., ARATA, Y., MANABE, S., YASUDA, T., and TADAKUMA, T., int. immuno/., 1990, 2, (6), 510–514.
  • Controlled-release microcapsule dosage form using biodegradable polymers containing a water-soluble peptide. OGAWA, Y., Funtai Kogaku Kaishi, 1990, 27, (8), 534–540.
  • Targeting drug therapy using temperature-sensitive liposomes containing antitumor drugs together with localized hyperthermia. OGAWA, Y., and TOGUSHI, H., Gan to Kagaku Ryoho, 1990, 17, (6), 1127–1133.
  • On stability of liposomes of synthetic phospholipids. OHKATSU, Y., KIKUCHI, Y., and KUSANO, T., Kogakuin Daigaku Kenkyu Hokoku, 1990, (68), 98–101.
  • pH-Responsive controlled release of liposomally entrapped material utilizing N-acylhomoserine derivative as the functional amphiphile. OKABE, H., KAMAGAMI, S., KAINOSE, H., GAMA, Y., and IsHIGAmi, Y., Nippon Kagaku Kaishi, 1990, (10), 1054–1058.
  • Effects of a diluent on the retarded-release property of acrylate methacrylate-salicylic acid coacervates. COKOR, R. S., and YAHAYA, M. A., Pharm. Res., 1990, 7, (11), 1208–1209.
  • Preferential adsorption of bovine serum albumin dimer onto polymer microspheres having a heterogeneous surface consisting of hydrophobic and hydrophilic parts. Oxus°, M., AZUME, I., and YAMAMOTO, Y., Colloid Polym. Sci., 1990, 268, (7), 598–603.
  • Studies on suspension and emulsion. CXXVI. Production of submicron-size multi-hollow polymer microspheres. OKUBO, M., KANAIDA, K., and FUJIMURA, M., Chem. Express., 1990,5, (10), 797–800.
  • Distribution of liposomes in tuberculous mice. OROZCO, L. C., FORERO, M., WASSERMAN, M., and AHUMADA, J. J., Tubercle, 1990, 71, (3), 209–214.
  • Macrophage-targeted polysaccharide microcapsules for antigen and drug delivery. OSTROFF, G. R., EASSON, D. D. JR, and JAmAs, S., Polym. Prepr. (Am. Chem. Soc., Div. Polym, Chem.), 1990, 31, (2), 200–201.
  • A novel type of microencapsulated parathion-methyl formulation and evaluation of its biological efficacy to Colorado potato beetles and other insect pests. OTTO, D., BEHNISCH, I., DIETRICH, K., and KOERNER, H. J., Arch. Phytopathol. Pflanzenschutz, 1990, 26, (2), 177–187.
  • Studies on the masking of unpleasant taste of beclamide: microencapsulation and tabletting. OZER, A. Y., and HINCAL, A. A., J. Microencapsulation, 1990, 7, (3), 327–339.
  • Study of apparent diffusion coefficient for zero-order release kinetics of sulfamethoxazole in gelatin-acacia microcapsules. PAL, P. R., and PAL, T. K., Acta. Pharm. Technol., 1988, 34, (4), 204–207.
  • Liposomes designed to avoid the reticuloendothelial system. PAPAHADJOPOULOS, D., and GABIZON, A., Frog. Clin. Biol. Res., 1990, 343, (Horiz. Membr. Biotechnol.), 85–93.
  • Liposomes loaded with nonionic contrast media hepatosplenic computed tomographic enhancement. PASSARIELLO, R., PAVONE, P., PATRIZIO, G., DI RENZI, P., MASTANTUONO, M., and GIULIANI, S., Invest. Radiol., 1990, (25), (Suppl. 1), S92–594.
  • Liposomes: the newer drug delivery system. PATHAK, K., SINGLA, A. K., and PATHAK, D., East Pharm., 1990, 33, (389), 37–39.
  • Vacuolar proton-ATPase of adrenal secretory granules. Rapid partial purification and reconstitution into proteoliposomes. PEREZ CASTINEIRA, J. R., and APPS, D. K., Biochem. J 1990, 271, (1), 127–131.
  • Anthracycline antibiotics with high liposome entrapment: structural features and biological activity. PEREZ SOLER, R., and PRIEBE, W., Cancer Res., 1990, 50, (14), 4260–4266. Artificial matrix barriers: a diffusion study utilizing dextrans and microspheres. PERSKY, B., and
  • HENDRIX, M. J., Anat. Rec., 1990, 228, (1), 15–22.
  • Clinical evaluation of liposomal tumor antigen vaccines in patients with stage-III melanoma. PHILLIPS, N. C., LOUTFI, A., KAREEM, A. M., SHIBATA, H. R., and BAINES, M. G., Cancer Detect. Prey., 1990, 14, (4), 491–496.
  • Immunoliposome targeting to CD4 positive cells in human blood. PHILLIPS, N. C., and TSOUKAS, C., Cancer Detect. Prey., 1990, 14, (3), 383–390.
  • Preparation of hemolysate-filled hexamethylene sebacamide microcapsules with controlled diameter. PONCELET DE SMET, B., PONCELET, D., and NEUFELD, R. J., Can. J. Chem. Eng., 1990, 68, (6), 443–448.
  • Copper phthalocyanine labelled magnetic microcapsules: preparation, and binding properties in vitro and in vivo for mutagens having planar molecular structure. POVEY, A. C., and O'NEILL, I. K., Carcinogenesis, 1990, 11, (11), 1989–1993.
  • Uptake and tissue distribution of liposomes after intraperitoneal administration to rainbow trout, Oncorhynchusmykiss (Richardson): a preliminary report. POWER, C. A., MARKHAM, R. J. F., and DONALD, A. W., J. Fish Dis., 1990, 13, (4), 329–332.
  • Trypsin purification by affinity binding to small unilamellar liposomes. POWERS, J. D., KILPATRICK, P. K., and CARBONELL, R. G., Biotechnol. Bioeng., 1990, 36, (5), 506–519.
  • Liposomes from the thermophilic Eubacterium therm us-SP: fluorescence polarization and permeability properties. PRADO, A., DA COSTA, M. M. S., and MADEIRA, V. M. C., Int. J. Biochem., 1990, 22, (12), 1497–1502.
  • Topical liposomal delivery of antibiotics in soft tissue infection. PRICE, C. I., HORTON, J. W., and BAXTER, C. R., J Surg. Res., 1990, 49, (2), 174–178.
  • The mechanism of the interaction of the pH-dependent cytostatic cauloside C with the membranes of tumor cells and liposomes. PROFOK'EVA, N. G., LIKHATSKAIA, G. N., AMININ, D. L., GAFUROV, IU. M., SASUNKEVICH, V. A., STRIGINA, L. I., and ANISIMOV, M. M., Izv. Akad. Nauk. SSSR (Biol.), 1990, (3), 338–342.
  • Comparison of kinetic parameters for acetylthiocholine soman ketamine and fasciculin towards acetylcholinesterase in liposomes and in solution. Puu, G., and Komi, M., Biochem. Pharmaco., 1990, 40, (10), 2209–2214.
  • Carbachol-fluorescent microspheres: a new method for behavioral neurobiology. In MANCIA, M. and MARINI, G. (eds), The Diencephalon and Sleep; Satellite Symposium of the Twelfth European Neuroscience Association, Stresa, Italy, 8–10 September 1989, 402 pp. Raven Press, New York, NY, USA, publ. 1990, pp. 65–76.
  • Liposome-encapsulated hemoglobin: an oxygen-carrying fluid. RABINOVICI, R., RUDOLPH, A. S., LIGLER, F. S., YUE, T. L., and FEUERSTEIN, G., Circ. Shock, 1990, 32, (1), 1–17.
  • Biological responses to liposome-encapsulated hemoglobin (LEH) are improved by a PAF antagonist. RABINOVICI, R., RUDOLPH, A. S., YUE, T. L., and FEUERSTEIN, G., Circ. Shock, 1990, 31, (4), 431–445.
  • Membrane alterations by liposomes to enhance clinical efficacy of cytotoxic drugs. RAHMAN, A., DUSRE, L., FORST, D., THIERRY, A., Ron, J. K., GREENSPAN, A., and TREAT, J., Prog. Clin. Biol. Res., 1990, 343, (Horiz. Membr. Biotechnol.), 281–304.
  • Studies on dosage microforms. XXI. Dosage forms of xanthinol nicotinate based on micro-capsules. RAE, J., CHALABALA, M., and NGUYEN, T. L., Cesk. Farm., 1990, 39, (2), 57–62.
  • Effect of surface geometry and morphic features on the flow characteristics of microsphere suspensions. RAMADAN, M. A., and TAWASHI, R., J. Pharm. Sci., 1990, 79, (10), 929–933.
  • Pharmacokinetics of Dermatophagoides pteronyssinus encapsulated in liposomes. RAMIREZ, J., AUDERA, C., SOLER, E., and CARREIRA, J., Clin. Exp. Allergy, 1990, 20, (Suppl. 1), 12.
  • Continuous cell cultures in fluidized-bed bioreactors: cultivation of hybridomas and recombi-nant Chinese hamster ovary cells immobilized in collagen microspheres. RAY, N. G., TUNG, A. S., HAYMAN, E. G., VOURNAKIS, J. N., and RUNSTADLER, P. W. JR, Ann. N .Y V. Acad. Sci., 1990, 589, (Biochem. Eng., 6), 443–457.
  • Albumin microspheres: effect of process variables on size distribution and in vitro release. REDDY, B. P., DORLE, A. K., and KRISHNA, D. R., Drug. Dev. Ind. Pharm., 1990, 16, (11), 1791–1803.
  • The influence of transmembrane ion gradients on the flux of weak acids and bases across liposomal systems. REDELMEIER, T. E., University of British Columbia, Vancouver, BC, Canada, Dissertation, 1989, no pagination.
  • Inhibition of expression of human immunodeficiency virus-1 in vitro by antibody-targeted liposomes containing antisense RNA to the env region. RENNEISEN, K., LESERMAN, L., MATTHES, E., SCHRODER, H. C., and MULLER, W. E., J. Biol. Chem., 1990, 265, (27), 16337–16342.
  • Ioxaglate-carrying liposomes computed tomographic study as hepatosplenic contrast agent in rabbits. REVEL, D., COROT, C., CARRILLON, Y., DANDIS, G., ELOY, R., and AMIEL, M., Invest. Radiol., 1990, 25, (Suppl. 1), S95–S97.
  • Dose-dependent variations in blood flow evaluation of canine nerve, nerve graft, tendon, and ligament tissue by the radiolabeled-microsphere technique. Ricci, K., WOOD, M. B., and ILSTRUP, D. M., J. Orthop. Res., 1990, 8, (6), 909–916.
  • Giant liposomes: a model system in which to obtain patch-clamp recordings of ionic channels. RIQUELME, G., LOPEZ, E., GARCIA, S. L. M., FERRAGUT, J. A., and GONZALEZ, R. J. M., Biochemistry, 1990, 29, (51), 11215–11222.
  • Sphingomyelin distribution in dissolved phospholipid liposomes. RIVNAY, B., and FISCHER, G., FIDIA Res. Ser., 1989, 20, (Neurochem. Aspects Phospholipid Metab.), 63–72.
  • Natipide II-a new simple liposome system. ROEDING, J., Seifen, Oele, Fette, Wachse, 1990, 116, (14), 509–515.
  • Solubilization of liposomes by weak electrolyte drugs. I. Propranolol. ROGERS, J. A., BETAGERI, G. V., and Cnoir, Y. W Pharm. Res., 1990, 7, (9), 957–961.
  • Transplantation of microencapsulated hepatocytes into analbuminemic rats. ROZGA, J., BELLEW, T. M., Mosclom, A. D., WILLIAMS, R. F., and DEMETRIOU, A., Hepatology, 1990, 12, (4, Pt 2), 863.
  • Property of purified dihydropyridine-sensitive calcium channel reconstructed in liposomes. ROZHMANOVA, 0., SOLIDATOV, N., STELMACH, L., and VORONINA, S., Cell Biol. Int. Rep., 1990, 14, (Abstr. Suppl.), 222.
  • Incorporation of the reovirus M cell attachment protein into small unilamellar vesicles: incorporation efficiency and binding capability to L929 cells in vitro. RUBAS, W., BANERJEA, A. C., GALLATI, H., SPEISER, P. P., and JOKLIK, W. K., J. Microencapsulation, 1990, 7, (3), 385–395.
  • beta-Bungarotoxin-mediated liposome fusion: spectroscopic characterization by fluorescence and ESR. RUFINI, S., PEDERSEN, J. Z., DESIDERI, A., and LULY, P., Biochemistry, 1990, 29, (41), 9644–9651.
  • Influence of average molecular weights of poly(m-lactic acid-co-glycolic acid) copolymers 50/50 on phase separation and in vitro drug release from microspheres. Ruiz, J. M., BUSNEL, J. P., and BENOIT, J. P., Pharm. Res., 1990, 7, (9), 928–934.
  • A study on the manufacture and in vitro dissolution of terbutaline sulfate microcapsules and their tablets. RUIZ, R., SAKR, A., and SPROCKEL, 0. L., Drug. Dev. Ind. Pharm., 1990, 16, (11), 1829–1842.
  • Interferon-gamma encapsulated into liposomes enhances the activity of monocytes and natural killer cells and has antiproliferative effects on tumor cells in vitro. RuTENFRANz, I., BAUER, A., and KIRCHNER, H., Blut, 1990, 61, (1), 30–37.
  • Effect of calcium channel blockers in platelet glycoprotein GP IIII-IIIA mediated calcium transit in liposomes. RYBAK, M. E., and RENZULLI, L., Circulation, 1990, 82, (4), (4, Suppl. 3), 111662.
  • Fibronectin fn inhibition of glycoprotein GP LIB-HIA mediated calcium transit into liposomes and thrombin activated platelets. RYBAK, M. E., and RENZULLI, L., Circulation, 1990, 82, (4. Suppl. 3), 111369.
  • Development of Tc-99m labeled activated carbon microspheres and clinical application. SAEKI, T., KARAKI, Y., MAEDA, M., HONDA, T., and Fujimmu, M., Nippon Geka Gakkai Zasshi, 1990, 91, (6), 729–740.
  • Microcapsules. SAGITANI, S., Kako Gtjutsu, 1990, 25, (3), 21–29.
  • Nickel/metal hydride battery using microencapsulated alloys. SAKAI, T., YUASA, A., MIYAMURA, H., KURIYAMA, N., and ISHIKAWA, H., Kidorui, 1990, 16, 94–95.
  • Interaction of cholesterol with various glycerophospholipids and sphingomyelin. SANKARAM, M. B., and THOMPSON, T. E., Biochemistry, 1990, 29, (47), 10670–10675.
  • Effect of pyrrolidone derivatives on lipid membrane and protein conformation as transdermal penetration enhancer. SASAKI, H., KISHIKAWA, M., NAKAMURA, J., and SHIBASAKI, J., J. Pharmacobio. Dyn., 1990, 13, (8), 468–474.
  • Interaction of liposomes with human erythrocytes. SATO, Y., NAKAJIMAYA, K., and Suancr, Y., Chem. Pharm. Bull., 1990, 38, (8), 2228–2232.
  • Intestinal calcium transport in systemic disease studies with brush-border membrane vesicles. SCHEDL, H. P., CHRISTENSEN, K., RONNENBERG, W., and THOMAS, S., Miner. Electrolyte Metab., 1990, 16, (2-3), 147–153.
  • Reconstitution of solubilized delta-opiate receptor binding sites in lipid vesicles. SCHEIDELER, M. A., and ZUKIN, R. S., J. Biol. Chem., 1990, 265, (25), 15176–15182.
  • Ischemia and reperfusion induced multilamellar vesicles in isolated rabbit hearts: time correlation between morphometric data and metabolic alterations. SCHRUVERS, A. H. G. J., DE GROOT, M. J. M., HEIJNEN, V. V. T., VAN DER VUSSE, G. J., FREDERIK, P. M., and RENEMAN, R. S., J. Mol. Cell Cardiol., 1990, 22, (6), 653–665.
  • Soybean phosphatidylcholine vesicles containing plant sterols: a fluorescence anisotropy study. SCHULER, I., DUPORTAIL, G., GLASSER, N., BENVENISTE, P., and HARTMANN, M. A., Biochim. Biophys. Acta., 1990, 1028, (1), 82–88.
  • Pore formation kinetics in membranes, determined from the release of marker molecules out of liposomes or cells. SCHWARZ, G., and ROBERT, C. H., Biophys. J., 1990, 58, (3), 577–583.
  • A pharmacokinetic and MRI study of unilamellar gadolinium-, manganese-, and iron-DTPA-stearate liposomes as organ-specific contrast agents. SCHWENDENER, R. A., WUETHRICH, R., DUEWELL, S., WEHRLI, E., and VON SCHULTHESS, G. K., Invest. Radiol., 1990, 25, (8), 922–932.
  • Comparative studies of the preparation of immunoliposomes with the use of two bifunctional coupling agents and investigation of in vitro immunoliposome-target cell binding by cytofluorometry and electron microscopy. SCHWENDENER, R. A., TRUER, T., SCFIOTT, H., LANGHALS, H., BARTH, R. F., GROSCURTH, P., and HENGARTNER, H., Biochim. Biophys. Acta, 1990, 1026, (1), 69–79.
  • Spontaneous incorporation of bacteriorhodopsin into large preformed vesicles. SCOTTO, A. W., and GOMPPER, M. E., Biochemistry, 1990, 29, (31), 7244–7251.
  • Cyclophosphamide, doxorubicin and vincristine with amphotericin B in sonicated liposomes as salvage therapy for small cell lung cancer (letter). SCULIER, J. P., KLASTERSKY, J., LIBERT, P., RAVEZ, P., BROHEE, D., VANDERMOTEN, G., MICHEL, J., THIRIAUX, J., BUREAU, G., SCHMERBER, J., et al., Eur. J. Cancer, 1990, 26, (8), 919–921.
  • Evidence for the formation of a chlorophyll aizeaxanthin complex in lecithin liposomes from fluorescence decay kinetics. SEARLE, G., BRODY, S. S., and VAN HOEK, A., Photochem. Photobiol., 1990, 52, (2), 401–407.
  • Differential movement of ions in artificial phospholipid vesicles. SEDGWICK, E. G., and BRAGG, P. D., FEBS Lett., 1990, 272, (1-2), 81–84.
  • Adhesion of vesicles. SEIFERT, U., and LIPOWSKY, R., Phys. Rev. A, 1990, 42, (8), 4768–4771. Design of nanoparticles of less than 50 nm diameter: preparation, characterization and drug loading. SEIJ0, B., FATTAL, E., ROBLOT TREUPEL, L., and COUVREUR, P., Int. J. Pharm., 1990,62, (1), 1–7.
  • Controlled release of 3',5'-diester prodrugs of 5-fluoro-2'-deoxyuridine from poly-L-lactic acid microspheres. SEKI, T., KAWAGUCHI, T., ENDOH, H., ISHIKAWA, K., JuNi, K., and NAKANO, M., J. Pharm. Sci., 1990, 79, (11), 985–987.
  • Protective effect of liposomal encapsulated superoxide dismutase on ischemically injured liver in the rat. SENGA, S., ONITUKA, A., HIROSE, H., YAMAMOTO, K., and NIWA, K., Transplant Proc., 1990, 22, (4), 2025–2026.
  • Reduction of doxyl stearates by ascorbate in unilamellar liposomes. SENTJURC, M., BACIC, G., and SWARTZ, H. M., Arch. Biochem. Biophys., 1990, 282, (2), 207–213.
  • Effect of subcutaneous administration of liposomes on the functional state of the organs and systems in experimental animals. SERGEEV, S. G., GILEV, A. P., UST'IANTSEVA, I. M., and GOLUBCHIKOVA, N. A., Vests,. Akad. Med. Nauk, SSSR, 1990, (6), 32–36.
  • Urinary excretion of apolipoproteins bound to HDL-like particles in rat nephrotic syndrome and their relation to plasma HDL. SHAFRIR, E., LEVY, E., and DECKELBAUM, R., Nephron, 1990, 56, (1), 24–29.
  • Polydispersity evaluation of polycyanoacrylate nanoparticles and nanocapsules by photon correlation spectroscopy. SHANKLAND, K., and WHATELEY, T. L., J. Controlled Release, 1990, 13. (2-3). 312–313.
  • Echocardiographic contrast enhancement with solid biodegradable microspheres. SHELL, W. E., and DEWOOD, M., Circulation, 1990, 82, (4, Supp1. 3), 11197.
  • Liposomes capture membrane proteins selectively from whole cell lysates of Entantoeba histolytica. SEIEN, P. S., NOKKAEW, C., Aunsto, C., and BAILEY, G. B., J. Cell. Biol., 1990, 111, (5, Pt 2), 74A.
  • Characterization of radical adducts formed during photochemical spin trapping in liposomes. SHFNG, P. G., FEIX, J., and KALYANARAMAN, B., Photochem. Photobiol., 1990, 52, (2), 323–331.
  • Superior antiproliferative effects mediated by interferon-alpha entrapped in liposomes against a newly established human lung cancer cell line. SHIN, D. M., FIDLER, I. J., BUCANA, C. D., FAN, D., HONG, W. K., and KILLION, J. J., J. Biol. Response Mod., 1990, 9, (4), 355–360.
  • Monochromosomal mouse microcell hybrids containing inserted selectable neo genes. SIDEN, T. S., HOGI.UND, M., and ROHME, D., Somat. Cell Mol. Genet., 1990, 16, (5), 425–435.
  • The formation of multilamellar vesicles from saturated phosphatidylcholines and phos-phatidylethanolamines: morphology and quasi-elastic light scattering measurements. SINGER, M. A., FINEGOLD, L., ROCHON, P., and RACEY, T. J., Chem. Phys. Lipids, 1990, 54, (2), 131–146.
  • Determination of antibodies to group B Salmonella and their somatic 0-antigen by complement-dependent lysis of liposomes. SKOPINSKAYA, S. N., YARKOV, S. P., and RURTSOV, I. V., Zh. Mikrobiol. Epidemiol. lmmunobiol., 1990, (4), 84–88.
  • Interaction of peptides corresponding to amino-terminal fragments of influenza virus hemagglutinin light chain HA-2 and transmembrane glycoprotein GP 41 of human immunodeficiency virus HIV-1 with artificial and natural lipid membranes. SLEPUSHKIN, V. A., MELIKYAN, G. B., SIDOROVA, M. V., KORNILAEVA, G. V., CIIUMAKOV, V. M., AZ'MUKO, A. A., ANDREEV, S. M., KALMANSON, A. E., and KARAMOV, E. V., Biol. Membr., 1990,7, (3), 261–273.
  • Liposomal vaccine to Streptococcus pneumoniae type 3 and 14. SNIPPE, H., VERHEUL, A. F. M., and VAN DAM, J. E.G., NATO ASI Ser, Ser. A, 1989, 179, (Immunol. Adjuvants Vaccines), 107–122.
  • Insulin administration via liposomes. SPANGLER, R. S., Diabetes Care, 1990, 13, (9), 911–922. The influence of various factors on the radiation induced structural damage and leakage of liposomes. SPRINZ, H., FRANCK, U., WINKLER, E., SCHAEFER, H., and KUROPTERA, Z. V., Radiat.
  • Phys. Chem., 1990, 36, (5), 645–649.
  • Inhibition of the phosphate self-exchange flux in human erythrocytes and erythrocyte ghosts. STADLER, F., and SCHNELL, K. F., J. Membr. Biol., 1990, 118, (1), 19–47.
  • Biological effect of liposomes in hypoxic conditions of various etiologies. STEFANOV, A. V., POZHAROV, V. P., MINIAILENKO, T. D., BRYGINSKII, S. A., SEREDENKO, M. M., and LISHKO, V. K., Vestn. Akad. Med. Nauk. SSSR, 1990, (6), 47–51.
  • Lipid conjugates of antiretroviral agents. I. Azidothymidine-monophosphate-diglyceride: anti-HIV activity, physical properties, and interaction with plasma proteins. STEIM, J. M., CAMAIONI-NETO, C., SARIN, P. S., SUN, D. K., SEHGAL, R. K., and TURCOTTE, J. G., Biochem. Biophys. Res. Commun., 1990, 171, (1), 451–457.
  • Treatment of spinal cord-induced experimental allergic encephalomyelitis in the Lewis rat with liposomes presenting central nervous system antigens. STEIN, C. S., ST LOUIS, J., GILBERT, J. J., and STREJAN, G. H., J. Neuroimmunol., 1990, 28, (2), 119–130.
  • A comparative study of the efficacy of praziquantel and its liposomal form in experimental opisthorchiasis. STRAZHENSKIKH, A. N., MOLOKOVA, 0. A., CHABANOV, M. K., BYCHKOV, V. G., and IAROTSKII, L. S., Med. Parazitol. (Mosk), 1990, (4), 39–41.
  • Influence of partition parameter on release of drug from adjuvant-containing charged film microcapsules. SULTZBAUGH, K. J., SPEAKER, T. J., ANGELINI, J., and SPEAKER, T. J., J. Microencapsulation, 1990, 7, (4), 505–510.
  • Modification in vitro and in vivo evaluation of microencapsulated rat islets transplantation into NOD mice and BB rats. SUN, A. M., LEVESQUE, L., Lum, Z., FAN, M., and NORTON, J., Diabetologia, 1990, 33, (Suppl.), A42.
  • Research on radiotherapy with phosphorus-32 glass microsphere. SUN WENHAO, ZHANG LISHU, and Li MAOLIANG, Hedongli Gongcheng, 1990, 11, (2), 171–174., Studies on targeting drug delivery system preparation of artesunate liposome. SUN, Y. Q., and XIE, X. H., Chin. J. Pharm., 1990, 21, (6), 265.
  • Effective transfer of membrane proteins from human erythrocytes to artificial boundary lipid-containing liposomes. SUNAMOTO, J., GOTO, M., and AKIYOSHI, K., Chem. Lett., 1990, (8), 1249–1252.
  • Protein microencapsulation of nonaqueous liquids. SusucK, K. S., and GRINSTAFF, M. W., J. Am. Chem. Soc., 1990, 112, (21), 7807–7809.
  • The application of liposomes to cosmetics. Suzum, K., and SAKON, K., Cosmet Toiletries, 1990, 105, (5), 65–66. 68–69. 72, 74–76. 78.
  • Detection of cell surface components using fluorescent microspheres. SYTKOWSKI, A. J., Methods in Enzymology, 1990, 184, (Avidin-Biotin Technology), 353–356.
  • Inhibition of HIV-1 in monocyteimacrophage cultures by 2',3'-dideoxycytidine-5'-triphosphate, free and in liposomes. SZEBENI, J., WAHL, S. M., BETAGERI, G. V., WAHL, L. M., GARTNER, S., POPOVIC, M., PARKER, R. J., BLACK, C. D. V., and WEINSTEIN, J. N., AIDS Res. Hum. Retroviruses, 1990, 62, (5), 691–702.
  • Protection of Toxoplasma gondii-infected mice by stearylamine-bearing liposomes. TACHIBANA, H., YOSHIHARA, E., KANEDA, Y., and NAKAE, T., J. Parasitol., 1990, 76, (3), 352–355.
  • Microencapsulation of a slightly soluble drug by surface neutralization method using an enteric polymer. TAICAHATA, H., KOIDA, Y., KOBAYASHI, M., and SAMEJIMA, M., Chem. Pharm. Bull., 1990, 38, (9), 2556–2560.
  • Polymerization of liposomes evaluated from molecular weight distribution of diene-type phospholipid polymers. TAKEOKA, S., KIMURA, N., OHNO, H., and TSUCHIDA, E., Polym. J., 1990, 22, (10), 867–874.
  • Targeting of liposomes via passively-adsorbed monoclonal antibodies to human hepato-cellular carcinoma cells in vitro. TAN, L., and GREGORIADIS, G., Asia Pac. J. Pharmacol., 1990, 5, (3), 219–222.
  • Interaction of the herbicide atrazine with model membranes I: physico-chemical studies on dipalmitoyl phosphatidylcholine liposomes. TANFANI, F., AMBROSINI, A., ALBERTINI, G., BERTOLI, E., CURATOLA, G., and ZOLESE, G., Chem. Phys. Lipids, 1990, 55, (2), 179–189.
  • Evaluation of membrane phase behavior as a tool to detect extrinsic protein-induced domain formation: binding of prothrombin to phosphatidylserineiphosphatidylcholine vesicles. TENDIAN, S. W., and LENTZ, B. R., Biochemistry, 1990, 29, (28), 6720–6729.
  • Barium sulfate-loaded P-hema microspheres as artificial emboli: preparation and properties. THANOO, B. C., and JAYAKRISHNAN, A., Biomaterials, 1990, 11, (7), 477–481.
  • Multidrug resistance in Chinese hamster cells: effect of liposome-encapsulated doxorubicin. TIIIERRY, A. R., JORGENSEN, T. J., FORST, D., BELL, J. A., DRITSCHILO, A., and RAHMAN, A., Cancer Commun., 1989, 1, (5), 311–316.
  • Microcapsules for cosmetic applications. TIIIES, C., Polym. Mater. Sci. Eng., 1990, 63, 243–244. Method for rapid separation of liposome-associated doxorubicin from free doxorubicin in plasma. THIES, R. L., COWENS, D. W., CULLIS, P. R., BALLY, M. B., and MAYER, L. D., Anal. Biochem., 1990, 188, (1), 65–71.
  • Recent developments with poly(lactide-co-glycolide) microspheres. TICE, T. R., LABRIE, F., McRAE, D. A., DILLON, D. L., MASON, D. W., and GILLEY, R. M., Polym. Prepr. . (Am. Chem. Soc., Div. Polym. Chem.), 1990, 31, (2), 185–186.
  • Electron microscopic studies of negatively stained liposomes and membrane in intrinsic polypeptide. TICKNER, A. L., LEA, E. J. A., and HORNS, R. W., Micron. Microsc. Acta, 1990, 21, (1-2), 91–100.
  • The parenteral controlled release of liposome encapsulated chloroquine in mice. TITULAER, II.
  • A. C., FLING, W. M. C., CROMMELIN, D. J. A., PEETERS, P. A. M., and ZUIDEMA, J., J. Pharm. Pharmacol., 1990, 42, (8), 529–532.
  • Interaction between cyclic dodecapeptides containing four ornithyl residues related to GS and liposomes. TOKUNAGA, N., ANDO, S., NISHIKAWA, H., and TAKIGUCHI, H., Pept. Chem., 1990,27, 139–144.
  • Liposomal amphotericin B ambisome treatment in bone marrow and solid organ transplant recipients. TOLLEMAR, J., RINGDEN, O., and TYDEN, G., J. Cell. Biochem., Suppl., 1990, (14, Pt A), 314.
  • Albumin microcapsules, microspheres and nanoparticles as new systems of medication administration. TORRADO, D. J. J., and CADORNIGA, C. R., Farm. Clin., 1989, 6, (10), 724–725. 728–730. 732–733.
  • Egg albumin microspheres containing paracetamol for oral administration. I. In vitro characterization. TORRADO, J. J., I LLum, L., CADORNIGA, R., and DAVIS, S. S., J. Microencapsul-ation, 1990, 7, (4), 463–470.
  • Egg albumin microspheres containing paracetamol for oral administration. II. In vivo investigation. TORRADO, J. J., ILLUM, L., CADORNIGA, R., and DAVIS, S. S., .1. Microencapsul-ation, 1.990, 7, (4), 471–478.
  • Antitumor activity of liposome-encapsulated doxorubicin in advanced breast cancer: phase II study. TREAT, J., GREENSPAN, A., FORST, D., SANCHEZ, J. A., FERRANS, V. J., POTKUL, L. A., WOOLLEY, P. V., and RAHMAN, A., J. Natl. Cancer Inst., 1990, 82, (21), 1706–1710.
  • Measurement of blood flow to the tibial diaphysis using 11-pm radioactive microspheres: a comparative study in the adult rabbit. TRIEFITT, P. D., and GREGG, P. J., J. Orthop. Res., 1990, 8, (5), 642–645.
  • Problems of the preparation and control of properties of sterile drug-containing liposomes.
  • TROFIMOV, V. I., and NISNEVICH, M. M., Vestn. Akad. Med. Nauk. SSSR, 1990, (6), 28–32. FITC-labeled lipopolysaccharide: use as a probe for liposomal membrane incorporation studies. TRUBETSKOI, V. S., KOSHKINA, V. N., OMECYANENKO. V. G., L'vov, V. L., DMITRIEV, B. A., PETROV, A. B., and TORCHILIN, V. P., FEBS Lett., 1990, 269, (1), 79–82.
  • Albumin microspheric ascorbic acid and adenine to preserve erythrocyte viability and oxygen carrying capacity. TRUTER, E. J., Med. Lab. Sci., 1990, 47, (3), 199–203.
  • Evaluation of liposomal forms of rifampicin and prodigiozan in the treatment of experimental chronic tonsillitis. TSYGANENKO, A. IA., FILATOV, V. F., DIKII, I. L., IAKOVENKO, V. D., VASICCHENKO, V. N., and BAZAVLUK, A. D., Antibiot. Khinnoter, 1990, 35, (6), 37–39.
  • Utility of artificial cell membranes. Production of useful substances and anticancer effect. UEOKA, R., and MATSUMOTO, Y., Kenkyu Hokoku-Kumamoto Kogyo Daigaku, 1990, 15, (1), 109–116.
  • Investigation of photochemical reduction of NADI- to NADH in liposomal solution. UMEDA, K., NAKAMURA, A., and TODA, F., Chem. Lett., 1990, (8), 1433–1436.
  • Paramagnetic liposomes as magnetic resonance contrast agents. UNGER, E., TiLcocx, C., AIIKONG, Q. F., and FRITZ, T., Invest. Radiol., 1990, 25, (Suppl. 1), S65–S66.
  • Biodistribution and clearance of liposomal gadolinium-DTPA. UNGER, E., CARDENAS, D., ZERELLA, A., FAJARDO, L. L., and TILCOCK, C., Invest. Radiol., 1990, 25, (6), 638–644.
  • Detergent solubilization of phospholipid vesicle. Effect of electric charge. URBANEJA, M. A., ALoNso, A., GONZALEZ MANAS, J. M., GONI, F. M., PARTEARROYO, M. A., TRIBOUT, M., and PAREDES, S., Biochem. J., 1990, 270, (2), 305–308.
  • Removal of HIV antigens and HIV-infected cells in vitro using immunomagnetic beads. USHIJIMA, H., HONMA, H., TSUCHIE, H., KITAMURA, T., and TAKAHASHI, I., J. Virol. Methods, 1990, 29, (1), 23–31.
  • Liposome-based vehicles for topical delivery. USTER, P. S., Drugs Pharm. Sci., 42, (Top. Drug Delivery Formulations), 327–348.
  • Release of a peptide drug from poly-2-hydroxyethyl methacrylic acid microspheres used for a bioadhesive drug delivery system. VAN HAT., D. A., LEHR, C. M., BOUWSTRA, J. A., and JUNGINGER, H. E., J. Controlled Release, 1990, 13, (2-3), 312.
  • Kinetics of liposome volume and permeability changes during the lipid phase transitions. VOINOVA, M. V., GALKIN, V. L., and KOSEVICH, A. M., Bioelectrochem. Bioenerg., 1990, 24, (2), 143–154.
  • Radioprotective efficacy of mexamine liposome fraction. VoLcxxov, V. A., MIKHAILOVA, N. YA, ROZENBERG, 0. A., LOSHAKOVA, L. V., MAKAR-EVA, N. V., and KHANSON, K. P., Radiobiologiya, 1990, 30, (2), 263–266.
  • Using magnet-controlled microcapsules in the combined chemothermomagnetic therapy of experimental tumors. VOLKONSKII, V. A., KHOLODOV, L. E., KAZARINA, E. K., and GUDOV, V. F., Byull. Eksp. Biol. Med., 1990, 109, (3), 295–296.
  • Cyclophosphamide loaded albumin microspheres: liver entrapment and fat in mice. VURAL, I., KAS, H. S., ERCAN, M. T., and HINCAL, A. A., Drug Dev. Ind. Pharm., 1990, 16, (11), 1781–1789. Cyclophosphamide loaded albumin microspheres. II. Release characteristics. VURAL, I., KAS, H. S., HINCAL, A. A., and CAVE, G., J. Microencapsulation, 1990, 7, (4), 511–516.
  • Lactic acid oligomer microspheres containing hydrophilic drugs. WADA, R., HYON, S. H., and IKADA, Y., J. Pharm. Sci., 1990, 79, (10), 919–924.
  • Stability of poloxamer and poloxamine coating films on polystyrene rtanoparticles. WALLIS, K. H., and MUELLER, R. H., Acta Pharm. Technol., 1990, 36, (3), 127–132.
  • Inhibitory effect of liposomes containing sulfatide or cholesterol sulfate on syncytium formation induced by bovine immunodeficiency virus-infected cells. WATARAI, S., ONUMA, M., YAMAMOTO, S., and YASUDA, T., J. Biochem. (Tokyo), 1990, 108, (4), 507–509.
  • In vivo evaluation of inflammatory responses to intra-peritoneal implantation of poly-t-lysine alginate microcapsules. WATERFALL, M., COLE, D., CHICHEPORTICHE, D., MCINTYRE, M., and BAIRD, J. D., Diabeto/ogia, 1990, 33, (Suppl.), A181, Advances on research of controlled and sustained release microspheres. WEI, S. L., and GAO, Z. H., Chin. J. Pharm., 1990, 21, (1), 29–32.
  • Studies on streptomycin albumin microspheres for injection. WEI, S. L., GAO, Z. H., HE, S. P., and Liu, H. J., Acta Pharm. Sin., 1990, 25, (4), 284–288.
  • Protein I (Por) of Neisseria gonorrhoeae as an immunogen: liposomes, proteosomes, and the lack of blocking antibodies. WETZLER, L. M., BLAKE MILAN, S., and GOTSCHI,ICH, E. C., Trans. Assoc. Am. Phys., 1989, 102, 78–90.
  • Biodistribution and clearance of contrast-carrying MREV liposomes. WHITE, C., SLIFKIN, M., SELTZER, S. E., BLAU, M., ADZAIVILI, I. K., and ADAMS, D. F., Invest. Radiol., 1990, 25,(10), 1125–1129.
  • Phospholipid vesicles containing bovine heart mitochondrial cytochrome c oxidase and subunit III-deficient enzyme: analysis of respiratory control and proton translocating activities. WILSON, K. S., and PROCHASKA, L. J., Arch. Biochem. Biophys., 1990, 282, (2), 413–420.
  • Mechanism of inhibition of lipid peroxidation by tamoxifen and 4-hydroxytamoxifen intro-duced into liposomes: similarity to cholesterol and ergosterol. WISEMAN, H., CANNON, M., ARNSTEIN, H. R. V., and HALLIWELL, B., FEBS Lett., 1990, 274, (1-2), 107–110.
  • A chemiluminescent, microparticle-membrane capture immunoassay for the detection of antibody to hepatitis B core antigen. WOLF-ROGERS, J., WEARE, J. A., RICE, K., ROBERTSON, E.
  • F., GUIDINGER, P., KHALIL, U.S., and MADSEN, G., J. Immunol. Methods, 1990, 133,(2), 191–198.
  • A single injection of a biodegradable microsphere formulation of the ACTH-(4-9) analog ORG 2766 accelerates functional recovery after brain damage. WOLTERINK, G., BOUWMAN, T. R. M., EENINK, M. J. D., DE NHS, H., and VAN REE, J. M., J. Pharm. Pharmacol., 1990, 42, (7), 508–510.
  • Nystatin-induced liposome fusion. A versatile approach to ion channel reconstitution into planar bilayers. WOODBURY, D. J., and MILLER, C., Biophys. J., 1990, 58, (4), 833–839.
  • The proteoliposomal steady state. Effect of size, capacitance and membrane permeability on cytochrome-oxidase-induced ion gradients. WRIGGLESWORTH, J. M., COOPER, C. E., SHARPE, M. A., and NICHOLLS, P., Biochem. J., 1990, 270, (1), 109–118.
  • Liposome-based flow injection enzyme immunoassay for theophylline. Wu, T. G., and DURST, R. A., Mikrochim. Acta, 1990, 1, (3-4), 187–195.
  • Encapsulation of antitumor drug methotrexate in liposome vesicles. Xu Bo, Surv QIXUN, ZHANG NIANBAO, XIE BINGHUA, and ZHANG JIONG, Hejishu, 1990, 13, (5), 317–320.
  • Nonaqueous polymer microspheres. YABUTA, M., Shikizai Kyokaishi, 1990, 63, (4), 209–216. Effect of tocopherols and tocotrienoIs on the physicochemical property of the liposomal membrane in relation to their antioxidative activity. YAMAOKA, M., and CARRILLO, M. J. H., Chem. Phys. Lipids, 1990, 55, (3), 295–300.
  • Binding of lysozyme on the surface of entrapped phosphatidylserine-phosphatidylcholine vesicles and an example of high-performance lipid vesicle surface chromatography. YANG, Q., and LUNDAHL, P., J. Chromatogr., 1990, 512, 377–386.
  • Studies on response characteristics of drug ISE's (VII)-performance and theoretical treat-ment of microcells connected in series. YAO, S. Z., MA, W. L., and NIE, L. H., Sci. China (B), 1990, 33, (6), 694–703.
  • Quantitative analysis of lipopolysaccharide antigen in the blood sera of salmonellosis patients by means of complement-dependent liposome lysis. YARKOV, S. P., SKOPINSKAYA, S. N., RUBTSOV, I. V., L'vova, 0. M., and MILYUTINA, L. N., Zh. Mikrobiol. Epidemiol. Immunobiol, 1990, (5), 65–69.
  • Topical application of liposomes. YAROSH, D. B., J. Photochem. Photobiol. B, 1990, 6, (4), 445–449. Enhancement of DNA repair of UV damage in mouse and human skin by liposomes containing a DNA repair enzyme. YAROSH, D. B., Tsmis, J., and YEE, V., J. Soc. Cosmet. Chem., 1990, 41, (1), 85–92.
  • Encapsulation of cells in agarose beads for use in the construction of human DNA libraries as yeast artificial chromosomes (YAC). YOKOYAMA, K., SAKA, F., KAI, T., and SOEDA, E., Jinrui Idengaku Zasshi, 1990, 35, (2), 131–143.
  • The enhancement of cationic liposome transfection efficiency mediated by oligonucleotides. YooN, K., and HOBBS, C. A., J. Cell. Biol., 1990, 111, (5, Pt 2), 380A.
  • A new biodegradable polydepsipeptide microsphere for application in drug delivery systems. YOSHIDA, M., ASANO, M., KUMAKURA, M., KATAKAI, R., MASHIMO, T., YUASA, H., IMAI, K., and YAMAMAKA, H., Colloid Polym. Sc., 1990, 268, (8), 726–730.
  • Microencapsulation of biocatalysts with ALG-PLL technique. YUAN ZHONGYI, Li XIONG, Li SHIYUN, and Wu YUN, Shengunt Gongcheng Xuebao, 1990, 6, (1), 81–84.
  • Microencapsulation of islets in barium alginate-beads: in vitro and in vivo experiments.
  • ZEKORN, T., KLENKE, C., SIEBERS, U., BRETZEL, R. G., ZIMMERMANN, U., and FEDERLIN, K., Diabetologia, 1990, 33, (Suppl.), A42.
  • Anti-metastatic activity of macrophages activated by liposomes containing muramyl dipeptide. ZHANG LINJIE, and YAO LIREN, Zhongguo Mianyixue Zazhi, 1989, 5, (6), 340–342. 346. In vitro study of the release of sulfadimidine from granules and microcapsules. ZHELYAZKOVA, ZII., Pharmazie, 1990, 45, (7), 532–533.
  • Liposomes and niosomes in pharmacy and cosmetics. Applications and models. ZIOLKOWSKY, B., Seifen, Oele, Fette, Wachse, 1990, 116, (10), 411–416.
  • Phosphatidic acid affects structural organization of phosphatidylcholine liposomes. A study of 1,6-dipheny1-1,3,5-hexatriene (DPH) and 1-(4-trimethylammonium-pheny1)-6-phenyl-1,3,5-hexatriene (TMA-DPH) fluorescence decay using distributional analysis. ZOLESE, G., GRATTON, E., and Cull/x.1'mA, G., Chem. Phys. Lipids, 1990, 55, (1), 29–39.
  • Preparation of sustained-release benzoic acid microcapsules by dropping method. Zou Zhongguo Yiyao Gongye Zazhi, 1990, 21, (3), 110–112.
  • Targeting behavior of hepatic artery injected temperature sensitive liposomal adriamycin on tumor-bearing rats. Zou, Y., UENO, M., YAMAGISHI, M., HORIKOSHI, I., YAMASHITA, I., TAZAWA, K., and Gu, X., Set. Cancer. Ther., 1990, 6, (3), 119–128.
  • Liposome-coupled translation in vitro: a novel approach to functional receptor expression.
  • ZOZULYA, S. A., GUREVICH, V. V., PoimovsKAYA, I. D., ZERF, E. P., OBUKHOVA, T. A., and BADALOV, P. R., J. Cell. Biochem., Suppl, 1990, (14, Pt E), 169.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.